Medifirst Solutions 10-K 15 Apr 19 2018 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Apr. 12, 2019	Jun. 30, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	Medifirst Solutions, Inc.
Entity Central Index Key	0001522704
Trading Symbol	MFST
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-K
Document Period End Date	Dec. 31, 2018
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2018
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	false
Entity Ex Transition Period	false
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Public Float			$ 491,063
Entity Common Stock, Shares Outstanding		5,808,883

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Current Assets:
Cash	$ 83,387	$ 287,569
Inventory	32,677	33,435
Prepaid items
Total current assets	116,064	321,004
Property, Plant and Equipment, net	592	1,232
Other Assets
Security Deposit	650	650
Intangible Asset - License Agreement, net	101,252	116,252
Total other assets	101,902	116,902
Total Assets	218,558	439,138
Liabilities
Accounts payable and accrued expenses	221,770	97,621
Accrued expenses - officer's compensation	388,981	401,079
Due to related party	8,921	8,921
Loans payable - stockholders	8,375	14,499
Note Payable for license agreement
Convertible notes payable	522,446	280,351
Convertible notes payable - related party	51,005	133,750
Derivative Liabilities	263,468	251,886
Total current liabilities	1,464,966	1,188,107
Commitments & Contingencies (Note 8)
Stockholders' Equity:
Common stock, $0.0001 par value; 4,000,000,000 shares authorized, 3,482,840 and 849,437 shares issued and outstanding, respectively	348	85
Additional paid in capital	3,486,856	2,916,024
Accumulated deficit	(4,733,663)	(3,665,129)
Total Stockholders' Equity	(1,246,408)	(748,969)
Total Liabilities & Stockholders' Equity	218,558	439,138
Series A preferred stock
Stockholders' Equity:
Preferred stock	50	50
Series B convertible preferred stock
Stockholders' Equity:
Preferred stock	1	1
Series C convertible preferred stock
Stockholders' Equity:
Preferred stock

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2018	Dec. 31, 2017
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	4,000,000,000	4,000,000,000
Common stock, shares issued	3,482,840	849,437
Common stock, shares outstanding	3,482,840	849,437
Series A preferred stock
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	500,000	500,000
Preferred stock, shares outstanding	500,000	500,000
Series B convertible preferred stock
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	50,000	50,000
Preferred stock, shares issued	8,000	8,000
Preferred stock, shares outstanding	8,000	8,000
Series C convertible preferred stock
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000	5,000
Preferred stock, shares issued	177	0
Preferred stock, shares outstanding	177	0

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Statements of Operations [Abstract]
Product sales, net	$ 6,550	$ 29,995
Consulting Income	22,625
Total Revenues	29,175	29,995
Cost of goods sold	757	1,058
Gross income	28,418	28,937
Expenses:
Officer's compensation	150,000	112,500
Advertising and promotion	5,001	63,548
Computer and internet	3,357	4,130
Consulting fees	363,208	435,589
Professional fees	130,821	224,286
Rent	30,930	20,713
Travel	7,494	12,903
Lab testing		7,107
Dues and subscriptions	2,269	3,720
General and administrative	99,464	96,012
Total operating expenses	792,544	980,508
Net loss from Operations before other income, expenses	(764,126)	(951,571)
Other income and (expense)
Interest expense	(680,909)	(405,144)
Interest income	2
Gain on extinguishment of debt	34,235
Change in fair value -derivatives	342,264	(201,121)
Net loss before provision for income tax	(1,068,534)	(1,557,836)
Provision for income taxes
Net Loss	$ (1,068,534)	$ (1,557,836)
Loss per common share - Basic and fully diluted	$ (0.61)	$ (2.82)
Weighted average number of shares outstanding - Basic and fully diluted	1,763,061	551,556

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity - USD ($)	Total	Common Stock	Additional Paid in Capital	Accumulated Deficit	Preferred Class A	Preferred Class B	Preferred Class C
Balance at Dec. 31, 2016	$ (874,266)	$ 23	$ 1,232,996	$ (2,107,293)	$ 5	$ 3
Balance, Shares at Dec. 31, 2016		225,848			50,000	26,100
Issuance of common shares upon conversions of notes payable	506,039	$ 43	505,996
Issuance of common shares upon conversions of notes payable, Shares		426,539
Issuance of common shares for services rendered	474,199	$ 19	474,180
Issuance of common shares for services rendered, Shares		188,000
Issuance of 450,000 shares of Series A Preferred Stock	45				$ 45
Issuance of 450,000 shares of Series A Preferred Stock, shares					450,000
Issuance of common shares upon conversion of 18,100 shares of Series B Preferred Stock	(1)	$ 1				$ (2)
Issuance of common shares upon conversion of 18,100 shares of Series B Preferred Stock, shares		9,050				(18,100)
Additional paid in capital from derivative liability on debt conversion	617,991		617,991
Adjustment for reverse stock split			84,861
Net Loss	(1,557,836)			(1,557,836)
Balance at Dec. 31, 2017	(748,969)	$ 85	2,916,024	(3,665,129)	$ 50	$ 1
Balance, Shares at Dec. 31, 2017		849,437			500,000	8,000
Issuance of common shares upon conversions of notes payable	131,960	$ 191	131,769
Issuance of common shares upon conversions of notes payable, Shares		1,913,850
Issuance of common shares for services rendered	82,134	$ 72	$ 82,062
Issuance of common shares for services rendered, Shares		719,553	204,182
Issuance of preferred shares for services rendered	204,182		$ 204,182				$ 177
Additional paid in capital from derivative liability on debt conversion	152,819		152,819
Net Loss	(1,068,534)			(1,068,534)
Balance at Dec. 31, 2018	$ (1,246,408)	$ 348	$ 3,486,856	$ (4,733,663)	$ 50	$ 1
Balance, Shares at Dec. 31, 2018		3,482,840			500,000	8,000	177

Consolidated Statement of Sto_2

Consolidated Statement of Stockholders' Equity (Parenthetical)	12 Months Ended
	Dec. 31, 2017shares
Statement of Stockholders' Equity [Abstract]
Issuance of Series A preferred stock	450,000
Issuance of common shares upon conversion of Series B preferred stock	18,100

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities:
Net loss	$ (1,068,534)	$ (1,557,836)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation & amortization expense	15,640	21,890
Gain on debt settlement	(34,235)
Stock Based Compensation	286,315	493,025
Change in assets and liabilities
Accounts payable and accrued expenses	112,051	84,811
Change in fair value - derivatives	(342,264)	201,121
Amortization of debt discount & other financing costs	610,511	321,983
Related party and stockholder's loan	(6,124)
Prepaid expenses		15,720
Inventory	758	(19,412)
Net cash used by operating activities	(425,882)	(438,698)
Cash flows from investing activities:
Net cash used by investing activities
Cash flows from financing activities:
Proceeds from stockholder loan		5,000
Principal payments on debt	(32,550)
Proceeds from sale of Convertible notes payable	254,250	556,250
Net cash provided by financing activities	221,700	561,250
Net increase (decrease) in cash	(204,182)	122,552
Cash at beginning of period	287,569	165,017
Cash at end of period	83,387	287,569
Cash paid during the period for:
Income taxes	1,169	1,826
Non-cash investing and financing activities:
Common stock issued for convertible debt-related party	30,195
Common stock issued for note interest and note conversions		5,230
Derivative liability extinguished upon conversion	152,820	617,990
Common stock issued for convertible debt with derivatives	109,224	544,323
Preferred stock exchanged for common stock		905
Accounts Payable exchanged for promissory note		15,000
New discounts associated with derivatives on convertible debt	328,666	505,607
Related party note reclassified to promissory note	$ 20,000

Nature of Operations and Summar

Nature of Operations and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2018
Nature of Operations and Summary of Significant Accounting Policies [Abstract]
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Note 1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization Medifirst Solutions, Inc. (“MSI” or the “Company”) was incorporated in Nevada in November 2010. The Company has not generated significant sales to date. The Company intends to have a diverse product line of consumer products. Since inception, the Company has been engaged in business planning activities, including researching the industry, identifying target markets for the Company’s products, developing the Company’s models and financial forecasts, performing due diligence regarding potential geographic locations most suitable for establishing the Company’s offices and identifying future sources of capital. At the present time, the Company is building products and affiliations in and related to the cosmetic healthcare industry. The company has started to hire a salesforce and sign distribution agreements in anticipation of future sales. In July 2016, Medifirst, in response to its Premarket Notification 510(k) submission for “The Time Machine” Series Laser, received clearance from the U.S. Food and Drug Administration (“FDA”) to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. The Company is actively putting together a sales and distribution team to offer our lasers in the US and foreign markets. Pursuant to a sale and purchase agreement dated August 19, 2015 between the Company and the Company’s president, the Company acquired 100% of the equity interests in Medical Lasers Manufacturer, Inc. (“MLM”) with the total purchase price of 20,000 shares of the Company’s common stock at $0.001 per share (or $20). The fair value of the acquired entity was $20. The transaction was considered as a business acquisition and accordingly the acquisition method of accounting has been applied. MLM had no assets at the date of the business combination. On April 18, 2018, the Company incorporated Concierge Concepts Rx (CCRx), in the State of New Jersey, to be an 80% majority-owned subsidiary. In consideration for his contribution of know-how, CCRx’s co-founder, Walter Molokie, CCRx has agreed to issue a 20% minority interest in CCRx to Mr. Molokie and/or his designees. On July 1, 2018 the Company acquired 100% of the equity interest in Concierge Concepts Rx, Inc. (“CCRx”) with the total purchase price of $20. The fair value of the acquired entity was $20 since the entity was just recently formed and had no identifiable assets or liabilities. The $20 cash payment is for the purchase of CCRx common stock upon acquisition. Medifirst launched Concierge Concepts Rx, a new division focused on the pharmaceutical industry.CCRx that provides unique specialty drug consulting and niche billing services to independent pharmacies and retail pharmacy chains. This division commenced operations in the quarter ended September 30, 2018 with limited activity and is included in the accompanying consolidated financial statements. The Consolidated financial statements include the accounts of MSI and its wholly owned subsidiaries, MLM and CCRx and its majority owned subsidiary, USA Pharma Corporation. All material intercompany balances and transactions have been eliminated in consolidation. There was no activity for USA Pharma Corporation for the year ended December 31, 2018. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company’s current technology. Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). In the opinion of management, all adjustments considered necessary for a fair presentation of the consolidated financial statements have been included. All such adjustments are of a normal recurring nature. The consolidated financial statements include the accounts of Medifirst Solutions Inc. and its wholly owned subsidiaries (Medical Laser Manufactures, Inc. and Concierge Concepts Rx) and its majority owned subsidiary (USA Pharma Corporation) (collectively referred to as the “Company”). All material intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the consolidated financial position of the Company as of December 31, 2018 and 2017, the consolidated results of its operations for the years ended December 31, 2017 and 2018, and the consolidated cash flows for the years ended December 31, 2018 and 2017. Some items in the prior year financial statements were reclassified to conform to the current presentation. Reclassifications had no effect on prior year net income or shareholders’ equity. Effective July 23, 2018, the Company effected a 1-for-1,000 reverse stock split of its issued and outstanding common stock. The number of shares of common stock issued and outstanding post- reverse stock split is 1,404,073. All fractional shares have been rounded up to the next whole share. There is no reduction in the number of the Company’s shareholders of record. Unless otherwise noted, impacted amounts and share information included in the financial statements and notes thereto have been retroactively adjusted for the reverse stock split as if such reverse stock split occurred on the first day of the first period presented. Revenue Recognition In general, the Company follows ASC 605 and records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. The following policies reflect specific criteria for the various revenues streams of the Company: Revenue is recognized at the time the product is delivered or services are performed. Provision for sales returns are estimated based on the Company’s historical return experience. Revenue is presented net of returns. The Company also derives consulting revenue from its CCRx division. Such revenue is recognized at the time services are performed. Accounts Receivable The Company extends credit to its customers in the normal course of business and performs ongoing credit evaluations of its customers, maintaining an allowance for potential credit losses. Accounts receivable is reported net of the allowance for doubtful accounts. The allowance is based on management’s estimate of the amount of receivables that will actually be collected. The Company has not recorded an allowance for doubtful accounts as of December 31, 2018 or 2017. There are no customer account receivables as of December 31, 2018 or 2017. Inventory Inventory consists of finished goods and is stated at the lower of cost (first-in, first-out) or market value. Finished goods inventory includes hand held laser devices, their carrying cases and goggles. Equipment Equipment, consisting of computer equipment, is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, of five years. Long-Lived Assets The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds the estimated future cash flows, an impairment loss will be recorded by the amount the carrying value exceeds the fair value of the asset. Intangible Asset- Licensing Agreement On March 8th 2016 (with an effective date of October 1, 2015), the company, through its wholly-owned subsidiary (“Licensee”), entered into a Product and Know-How License Agreement (“Agreement”) with a Florida Corporation (“Licensor”) which is owned by a related party - the son of the Company’s CEO to license certain laser technology (the “Technology”). The license provides an irrevocable, nontransferable, royalty-bearing license, with a right of sublicense with respect to the Technology (the “License”), throughout the Territory in the Field of Use, whether or not under the Licensed Patent, to: - use or submit or deliver the Technology and/or any Product to any regulatory body throughout the Territory for purposes of obtaining approval to make, Sell, offer for Sale, import, export and distribute the Technology or Products; and - use or submit or deliver the Technology and/or any Product to any regulatory body throughout the Territory for purposes of obtaining approval to make, Sell, offer for Sale, import, export and distribute the Technology or Products; and - use or copy the Technology and/or any Product; and - market, make, have made, Sell, offer for Sale, import and distribute Products; and - sublicense the Technology; and - prepare, or have prepared on its behalf, modifications, enhancements and/or derivative works of the Technology. In connection with the license granted, Licensor hereby grants to Licensee a license to the Licensed Patents, whether now existing or hereafter acquired. The consideration for the licensing agreement consisted of the issuance of 25,000 Series B Preferred stock shares to the Licensor (at par) plus a $150,000 promissory note issued by the Company to the licensor. On September 15, 2017 the Note was amended to include provisions to allow conversion of the Note into common stock of the Company. On September 25, 2017, $16,250 in principal on this note was satisfied by the conversion into 25,000,000 shares of the Company’s common stock. During the quarter ended June 30, 2018, the original noteholder assigned $20,000 in principal to an unrelated third-party. The principal balance on this note as of December 31, 2018 is $51,005 to the original noteholder and $16,650 in principal balance to the new unrelated third-party noteholder. There were $32,550 in cash principal paydowns to the original noteholder during the year ended December 31, 2018. There were an additional $33,345 in conversions to common stock that took place on these two notes during the year ended December 31, 2018. The last part of the consideration in this license agreement is the royalty payments which have not taken effect yet since they are based on sales for which the company has had only minimum thus far. The licensing agreement is for a ten year period effective from October 1, 2015. The cost of the licensing agreement is being amortized over it’s ten-year period and charged to income on a straight-line basis. Product Warranty We generally provide a one-year warranty on our products. Currently no material evaluations or studies have been performed to obtain warranty data since there are so few sold products outstanding. As sales increase, the Company will estimate future warranty costs from historical data and trends of product reliability and costs of repairing and replacing defective products. Debt Issue Costs and Debt Discount The Company may pay debt issue costs, and record debt discounts in connection with raising funds through the issuance of convertible debt. These costs are amortized over the life of the debt to interest expense. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts are immediately expensed. Beginning in 2015, the Company adopted ASU 2015-03: Simplifying the Presentation of Debt Issuance Costs and has reflected the deferred financing costs as a direct reduction of the related debt (See table included in Note 5 to Consolidated Financial Statements). Original Issue Discount For certain convertible debt issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt. Derivative Liabilities Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. The Company assessed its securities for purposes of determining the proper accounting treatment and valuation as set forth in the Statement of Financial Accounting Standard ASC 820–10–35–37 Fair Value in Financial Instruments Accounting for Derivative Instruments and Hedging Activities In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments. Once the derivative liabilities are determined, they are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the condensed consolidated balance sheets and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Financial Instruments The carrying amounts reported in the balance sheets for cash, accounts receivable, accounts payable, and other accrued liabilities approximate their fair values. Segment Information The Company follows Accounting Standards Codification (“ASC”) 280, “Segment Reporting”. The Company currently operates in a single segment and will evaluate additional segment disclosure requirements as it expands its operations. Net Income (Loss) Per Common Share The Company calculates net income (loss) per share based on the authoritative guidance. Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares and dilutive common stock equivalents outstanding. During periods in which the Company incurs losses, common stock equivalents, if any, are not considered, as their effect would be anti-dilutive. As described in Note 5 to the financial statements, as of December 31, 2018, convertible debt can be converted into approximately 727,323 shares of common stock. Income Taxes The Company utilizes the accrual method of accounting for income taxes. Under the accrual method, deferred tax assets and liabilities are determined based on the differences between the financial reporting basis and the tax basis of the assets and liabilities, and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. An allowance against deferred tax assets is recognized, when it is more likely than not, that such tax benefits will not be realized. The Company recognizes the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount recognized in the financial statements is the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the threshold, no financial statement benefit is recognized. The Company recognizes interest and penalties, if any, related to uncertain tax positions in income tax expense. The Company did not have any unrecognized tax benefits as of December 31, 2018, and does not expect this to change significantly over the next 12 months. Stock-Based Compensation The Company accounts for equity instruments issued to employees in accordance with ASC 718, Compensation - Stock Compensation. ASC 718 requires all share-based compensation payments to be recognized in the financial statements based on the fair value on the issuance date. Equity instruments granted to non-employees are accounted for in accordance with ASC 505, Equity. The final measurement date for the fair value of equity instruments with performance criteria is the date that each performance commitment for such equity instrument is satisfied or there is a significant disincentive for non-performance. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At December 31, 2018, the Company had $83,387 in cash equivalents. Recent Pronouncements In May 2014, FASB and IASB issued a new joint revenue recognition standard that supersedes nearly all GAAP guidance on revenue recognition. The core principle of the standard is that revenue recognition should depict the transfer of goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard is effective for the Company to annual reporting periods beginning after December 15, 2017 (that is, a public organization is required to apply the new revenue standard beginning in the first interim period within the year of adoption). Additionally, the Board decided to permit public organizations to adopt the new revenue standard early, but not before the original public organization effective date (that is, annual periods beginning after December 15, 2016). A public organization should apply the new revenue standard to all interim reporting periods within the year of adoption. The Company has evaluated the impact of this ASU on the consolidated financial statements and has determined, at this time, the ASU’s implementation would not have a material impact on revenue recognition. See below - Accounting Standards Update 2016-10 - Revenue from Contracts with Customers (Topic 606) Identifying Performance Obligations and Licensing In June 2018, the FASB issued Accounting Standards Update 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). ASU 2018-07 expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 also clarifies that Topic 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Revenue from Contracts with Customers (Topic 606). ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company will adopt the provisions of ASU 2018-07 in the quarter beginning January 1, 2019. The adoption of ASU 2018-07 is not expected to have any impact on the Company’s financial statement presentation or disclosures. The Company does not plan to have any equity instruments that will need revaluation under this new standard. In April 2016, the FASB issued Accounting Standards Update 2016-10 - Revenue from Contracts with Customers (Topic 606) Identifying Performance Obligations and Licensing. The core principle of the guidance in Topic 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps: 1. Identify the contract(s) with a customer. 2. Identify the performance obligations in the contract. 3. Determine the transaction price. 4. Allocate the transaction price to the performance obligations in the contract. 5. Recognize revenue when (or as) the entity satisfies a performance obligation. The amendments in this Update do not change the core principle of the guidance in Topic 606. Rather, the amendments in this Update clarify the following two aspects of Topic 606: identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas. The Company is currently evaluating the impact of this ASU on the consolidated financial statements. In February 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220)”. The objective of the ASU is to allow a reclassification from accumulated comprehensive income (loss) to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act and will improve the usefulness of information reported to financial statement users. This ASU is effective for interim and annual reporting periods beginning after December 15, 2018, and early adoption is permitted. The Company is currently evaluating the impact of this ASU on the consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, “Leases” (Topic 842), in order to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet for those leases classified as operating leases under previous GAAP. ASU 2016-02 requires that a lessee should recognize a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term on the balance sheet. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 (including interim periods within those periods) using a modified retrospective approach and early adoption is permitted. The Company will adopt ASU 2016-02 in the first quarter of 2019. A modified retrospective transition approach is required, applying the new standard to all leases existing at the date of initial application. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. If an entity chooses the second option, the transition requirements for existing leases also apply to leases entered into between the date of initial application and the effective date. The entity must also recast its comparative period financial statements and provide the disclosures required by the new standard for the comparative periods. The Company will adopt the new standard on January 1, 2019 and use the effective date of initial application. Consequently, financial information will not be updated and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company expects to elect the “package of expedients”, which permits the Company not to reassess under the new standard the Company’s prior conclusions about lease identification and initial direct costs. The Company does not expect to elect the use-of hindsight or the practical expedient pertaining to land easements, the latter not being applicable to the Company. The new standard also provides practical expedients for the Company’s ongoing accounting. The Company currently expects to elect the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, the Company will not recognize ROU assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets in transition. The Company also expects to elect the practical expedient to not separate lease and non-lease components for all of its leases other than leases of real estate. The Company expects the most significant change will be related to the recognition of right-of-use assets and lease liabilities on the Company’s balance sheet for real estate operating leases. The Company is currently in the process of evaluating the impact of ASU 2016-02 on the Company’s outstanding leases. The Company has not yet determined, as a result of the adoption of this guidance, how much right-of-use assets and lease liabilities will be recorded. The Company also expects that the adoption of this guidance will result in additional lease-related disclosures in the footnotes to its consolidated financial statements. During the fiscal year ended December 31, 2018, Company was an “emerging growth company” as defined in Section 2(a)(19) of the Securities Act and the extended transition period applies to all aforementioned ASUs, until such time as the Company is no longer an “emerging growth company”. However, as of January 1, 2019, the Company no longer meets the definition of an “emerging growth company” and for periods subsequent to December 31, 2018, the Company will cease to take advantage of the extended transition period applied to such ASUs.

Property, Plant and Equipment (

Property, Plant and Equipment (Net)	12 Months Ended
	Dec. 31, 2018
Property, Plant and Equipment (Net) [Abstract]
PROPERTY, PLANT AND EQUIPMENT (NET)	Note 2. PROPERTY, PLANT AND EQUIPMENT (NET) Equipment is recorded at cost and consisted of the following at December 31, 2018 and December 31, 2017: December 31, 2018 December 31, 2017 Computer equipment $ 8,956 $ 8,956 Less: accumulated depreciation (8,365 ) (7,725 ) $ 592 $ 1,232 Depreciation expense was $640 and $640, for the years ended December 31, 2018 and 2017 respectively.

Due to Related Party

Due to Related Party	12 Months Ended
	Dec. 31, 2018
Due to Related Party [Abstract]
DUE TO RELATED PARTY	Note 3. DUE TO RELATED PARTY The Company was indebted to a related party through common management in the amount of $8,921 at December 31, 2018 and December 31, 2017, respectively. The loan bears no interest and is payable on demand. See Note 10 for additional related party transactions.

Loans Payable - Stockholders

Loans Payable - Stockholders	12 Months Ended
	Dec. 31, 2018
Loans Payable - Stockholders [Abstract]
LOANS PAYABLE - STOCKHOLDERS	Note 4. LOANS PAYABLE - STOCKHOLDERS During the periods ended December 31, 2018 and 2017 a stockholder of the Company advanced the Company $557 and $-0- respectively. The loan has a balance of $8,955 at December 31, 2018 and $8,398 at December 31, 2017, respectively. The loan bears no interest and is payable on demand. In December 2012, the Company issued a promissory note to a stockholder in the amount of $5,000 with interest at 10% per annum. Principal and interest were due and payable on June 2, 2013. In April 2014, the note was amended to provide the note holder with the option to convert the note to the Company’s common stock at $0.0001 per share. Subsequently, in 2014, in a private transaction, the note holder transferred $2,500 of note principal to third parties and the new holders converted their holdings into 2,500 shares of the Company’s common stock. During 2015, the original note holder transferred an additional $2,400 of note principal to third parties who converted their holdings into 2,400 shares of the Company’s common stock. At December 31, 2018 and December 31, 2017, the loan balance was $100 and $100, respectively. At December 31, 2018 and December 31, 2017, the Company was indebted to a stockholder in the amount of $1,000 and $1,500, respectively. The loan has an interest rate of 26.7%. In February 2017 the note was sold to another investor and that noteholder converted $500 in principal into 5,000 shares of common stock. Principal and accrued interest were due and payable on January 1, 2014.

Convertible Notes Payable

Convertible Notes Payable	12 Months Ended
	Dec. 31, 2018
Convertible Notes Payable [Abstract]
CONVERTIBLE NOTES PAYABLE	Note 5. CONVERTIBLE NOTES PAYABLE Note Payable-BS In March 2011, the Company issued $800 aggregate principal amount of 6% convertible notes due in January 2012. Interest on the notes accrue at the rate of 6% per annum and are payable when the notes mature. The notes matured prior to conversion but have not been repaid. Interest continues to accrue at the rate of 6% per annum. The holder of one of the notes converted $110 of note principal into 1,100 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received June 2013 $ 70 $ 0.0001 700 August 2013 $ 40 $ 0.0001 400 In August 2013, in a private transaction, the same note holder transferred $330 of the remaining note principal plus $55 in accrued interest to a third party. In August 2013, in a private transaction, the new note holder transferred $5 of the remaining note principal to a third party who then converted the note into 50 shares of common stock. In September 2013, the new note holder converted $100 of note principal into 1,000 shares of common stock. In September 2013, in a private transaction, the new note holder transferred $35 of the remaining note principal to a third party who then converted the note into 350 shares of common stock. In November and December 2013, the new note holder converted an additional $90 of note principal into 900,000 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received November 2013 $ 40 $ 0.0001 400 December 2013 $ 50 $ 0.0001 500 In March and April 2014, the new note holder converted an additional $90 of note principal into 900,000 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received March 2014 $ 50 $ 0.0001 500 April 2014 $ 40 $ 0.0001 400 Subsequent to these conversions there remains $125 in note principal outstanding at December 31, 2018. Note Payable-SF In July 2013, the holder of the second note converted $240 of note principal into 400 shares of the Company’s common stock at $0.0006 per share. At December 31, 2018 and December 31 2017, the note had a remaining principal balance of $60 and $60, respectively. At any time on or after the maturity date, the holders of the notes, have the option of converting any of the unpaid principal and interest into the Company’s common stock. The notes plus any accrued but unpaid interest are convertible at the rate of $0.0001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 347,936 shares at December 31, 2018 and 84,859 shares at December 31, 2017. Note Payable-RK In May 2012, the Company issued a $25,000 6% per annum note that matured in November 2012. In December 2012 the note was amended to be a convertible note. Interest on the note accrues interest at 6% per annum and is payable when the note matures. The holder of the $25,000 note had the option of converting it at any time prior to maturity. The note plus any accrued but unpaid interest were convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock. The holder of the note converted $1,010 of note principal into 1,010 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received December 2012 $ 150 $ 0.001 150 January 2013 $ 660 $ 0.001 660 March 2013 $ 200 $ 0.001 200 In July 2013, the Company retired $14,000 of note principal in payment for consulting services provided to the note holder. In July 2013, the note holder converted $300 of note principal into 300 shares of the Company’s common stock. In July 2013, in a private transaction, the note holder transferred the remaining note principal balance of $9,690 to a third party (See Note Payable-NW Note Payable-NW After receiving the transfer of the principal balance of $9,690 in July 2013 in the private transaction noted in Note Payable-RK In October 2013, the note holder converted $400 of note principal into 400 shares of the Company’s common stock at $0.001 per share. In October 2014, the note holder converted $1,100 of note principal into 1,100 of the Company’s common stock.The note holder has the option of converting the balance at any time with the approval of the Board of Directors. The note plus any accrued but unpaid interest are convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 347,936 shares at December 31, 2018 and 84,858,757 shares at December 31, 2017. In August 2016, the note holder converted $3,000 of note principal into 3,000,000 shares of the Company’s common stock. At December 31, 2018 and December 31, 2017, the remaining principal balance on this portion of the note is $715 and $715 respectively. Note Payable-MC #2 In April 2015, the Company issued a $3,000 8% per annum note that matures in October 2015. The holder of the note has the right to convert the principal into shares of the Company’s common stock at any time 180 days after the closing date at $0.0001 per share. Interest on the note accrues interest at 8% per annum and is payable when the note matures. During January 2017, the current noteholder converted $1,100 in principal balance into 11,000 shares of common stock. During the same period, the current noteholder transferred $600 of the remaining principal balance to another investor who then converted the entire principal balance he received into 6,000 shares of common stock. During April 2017, the current noteholder converted $410 of remaining principal into 6,000 shares of common stock. There remains $890 in principal balance at December 31, 2018 with the current noteholder and $890 in principal balance with the original noteholder at December 31, 2017. Convertible Note Payable-LGC (8%) On January 7 2016, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an accredited investor (the “Investor”) for the sale of convertible redeemable notes in aggregate principal amount of $251,803. On January 7, 2016, the Company and the Investor conducted the first closing under the Purchase Agreement, pursuant to which the Company issued to the Investor (i) a convertible redeemable note in principal amount of $105,000 containing an original issue discount of $20,000 (the “$105K Note”); and (ii) a convertible redeemable note in principal amount of $50,000 (the “$50K Note” and together with the $105K Note, the “Notes”). Under the Purchase Agreement, on March 15, 2016 and June 15, 2016, the Company and the Investor conducted additional closings for the sale and purchase of additional notes having the same terms as the Notes in principal amounts equal to $50,000 and $46, 803, respectively (see Convertible Notes Payable-LGC (8%) BEN Convertible Notes Payable-LGC (8%) BEN In consideration for the issuance of the $105K Note, on January 13, 2016, the Company received net proceeds (after deducting the original issue discount and legal fees) in the amount of $75,697. In consideration for the issuance of the $50K Note, the Investor issued to the Company a $50,000 fully-collateralized secured promissory note (the “Investor Note”), pursuant to which the Investor agreed to pay the Company $50,000 on or before April 30, 2016. The Notes, which are due on January 7, 2017, bear interest at the rate of 8% per annum. Subject to a beneficial ownership limitation equal to 9.99%, principal and interest on the Notes is convertible into shares of the Company’s common stock (“Common Stock”) at a conversion price equal to 55% of the lowest trading price of Common Stock during the 20 trading day period prior to conversion. In accordance with the terms of the Purchase Agreement, the investor and the Company closed on the two outstanding notes ($50,000 and $46,803) in May and June 2016 when the Company received the cash funding. During April 2017 the noteholder converted the entire principal balance of the $50,000 note into common stock of the Company. During June 2017 the noteholder converted $16,000 of the remaining principal of the $46,803 note into common stock of the Company. In July and September 2017 the noteholder converted the remaining $30,803 of the note’s principal balance into common stock. As a result, there is no principal balance remaining on either note as of December 31, 2018 and December 31, 2017. Convertible Notes Payable-SO (8%) On May 2, 2016, the Company issued to an Investor a convertible redeemable note in the principal amount of $57,750 (“the Note”). The Note, which matures on May 2, 2017, pays interest at the rate of 8% per annum. The note contains a 10% original issue discount. The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company’s common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion. During the quarter ended March 31, 2017 the noteholder converted $32,298 of the principle balance into 23,490 shares of common stock thereby leaving a principal balance of $25,452 on the note at December 31, 2017. During the first quarter of 2018, the noteholder converted $23,000 of the principle balance into 122,727 shares of common stock thereby leaving a principal balance of $2,452 on the note at June 30, 2018. During the quarter ended September 30, 2018, the noteholder converted the remaining balance of the note into 148,316 shares on common leaving no balance due on the note as of December 31, 2018. There is $12,896 in accrued interest and penalty assessments on this note as of December 31, 2018 which is included in accrued expenses payable on the balance sheet. Convertible Notes Payable-BBCG (9%) On October 11, 2016, the Company issued to an Investor a convertible note in the principal amount of $157,895 (“the Note”). The Note, which matures on March 27, 2018, pays interest at the rate of 9% per annum. The note contains an original issue discount in the amount of $7,895. The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company’s common stock at the price equal to 57.5% of the lowest trading price for the twenty prior trading days including the date of conversion. During April and June of 2017, the noteholder converted the entire remaining principal balance of the note into common stock of the Company. There is no principal balance remaining on the note as of December 31, 2018 and December 31, 2017. Convertible Notes Payable - Funding (8%) On May 1 2017, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an accredited investor (the “Investor”) for the sale of 8 convertible redeemable notes in aggregate principal amount of $1,012,500. On May 1st, 2017 and June 2, 2017, the Company and the Investor conducted the first two closings under the Purchase Agreement, pursuant to which the Company issued to the Investor (i) a convertible redeemable note in principal amount of $131,250 (the “$131K Note”); and (ii) a convertible redeemable note in principal amount of $125,000 (the “$125K Note”). On July 10, 2017 and August 7, 2017, the Company and the Investor conducted the second two closings under the Purchase Agreement, pursuant to which the Company issued to the Investor two convertible redeemable notes each in the principal amount of $125,000; Under the Purchase Agreement, on January 1, 2018, February 2, 2018, March 10, 2018 and April 7, 2018 the Company and the Investor expected to conduct additional closings for the sale and purchase of additional notes having the same terms as the Notes in principal amounts equal to $131,250, $125,000, $125,000 and $125,000 respectively (the “back-end notes”). However, all these “back-end notes” were cancelled in early 2018 and will not fund. Accordingly, all the “back-end” notes were removed from the books at December 31, 2017 along with the associated investor notes receivable. In addition, all previously accrued interest expense and interest income as been removed on these “back-end notes” for the period ended December 31, 2017. In consideration for the issuance of the $131K Note and the $125K Note, on May 1, 2017 and June 2, 2017 and for the two $125k Notes on July 10, 2017 and August 7, 2017, the Company received net proceeds (after deducting $25,000 in legal fees) in the amount of $481,250. In consideration for the issuance of the $131K and the three $125k Notes, the Investor issued to the Company a $131,250 fully-collateralized secured promissory note and three $125,000 fully-collateralized secured promissory notes (the “Investor Notes”), pursuant to which the Investor agreed to pay the Company $131,250 and $375,000 on or before January 1, 2018, February 2, 2018, March 10, 2018 and April 7, 2018 respectively. These Notes (often referred to as “back-end Notes”), bear interest at the rate of 8% per annum. However, all these “back-end notes” were cancelled in early 2018 and will not fund. According, all the “back-end” notes were removed from the books at December 31, 2017 along with the associated investor notes receivable. In addition, all previously accrued interest expense and interest income as been removed on these “back-end notes” for the period ended December 31, 2017. The two notes issued May 1,2017 ($131,250) and June 2, 2017 ($125,000) became convertible on October 28, 2017 and December 4, 2017 respectively and required derivative treatment at that time. The embedded derivative was bifurcated and accounted for separately along with the derivative discount. The derivative liability is marked-to-market each quarter with the resulting gain or loss valuation being reported in the statement of operations. During the quarter ended December 31, 2017 (after the six-month waiting period) the holder of the original note in the principal amount of $131,250 converted $21,500 and $15,350 of the note’s principal balance into 35,058 and 39,714 shares of the Company’s common stock, respectively. The principal balance remaining on this convertible note is $94,400 as of December 31,2017. During the quarter ended March 31, 2018 the holder of the original note converted, through four separate conversion transactions, a total of $38,870 of the note’s principal balance into total of 193,384 shares of the Company’s common stock. During the quarter ended June 30, 2018 the holder of the original note converted $10,030 of the note’s principal balance into total of 62,015 shares of the Company’s common stock. During the quarter ended September 30, 2018 the holder of the original note converted $2,200 of the note’s principal balance into total of 69,439 shares of the Company’s common stock. During the quarter ended December 31, 2018 the holder of the original note converted $10,640 of the note’s principal balance and $1,312 of accrued interest into total of 148,545 shares of the Company’s common stock. The principal balance remaining on this convertible note is $32,660 as of December 31, 2018. Convertible Notes Payable - JR (5%) On August 2, 2017 the Company issued a convertible note payable (promissory note) to an investor in the principal amount of $50,000. The note matures on August 2, 2018 and bears interest at 5%. The note holder has has the right at any time on or after the day that is six months from August 2, 2018 to convert any part or all of the outstanding unpaid principal balance into shares of the Company’s common stock at a fixed price of .003 per share. The embedded derivative on the note was valued and bifurcated effective October 1, 2018. During the quarter ended December 31, 2018, $4,500 in principal on this note was satisfied by the noteholder converting such amount into 150,000 shares of the Company’s common stock. The remaining principal balance outstanding on the note is $45,500 as of December 31, 2018. Convertible Notes Payable - MLM (10%) As more fully described in Note 1 to the financial statements, on March 8th 2016 (with an effective date of October 1, 2015), the company, through it’s sole wholly-owned subsidiary (“Licensee”), entered into a Product and Know-How License Agreement (“Agreement”) with a Florida Corporation (“Licensor”) which is owned by a related party - the son of the Company’s CEO. The consideration for the licensing agreement consisted of the issuance of 25,000 Series B Preferred stock shares to the Licensor (at par) plus a $150,000 promissory note issued by the Company to the licensor. During the quarter-ended June 30, 2017, $18,986 in accrued interest was satisfied through the issuance of 17,273 shares of the Company’s common stock. On September 15, 2017 the Note was amended to include provisions to allow conversion of the Note into common stock of the Company. At such time the Note was valued with it’s embedded derivative and discount. On September 25, 2017, $16,250 in principal on this note was satisfied by the conversion into 25,000 shares of the Company’s common stock leaving a balance on the note of $133,750 at December 31, 2017. During the year ended December 31, 2018 the Company made cash paydowns to the noteholder in the total amount of $32,550. In addition, $30,195 in principal balance on the note was converted into 495,000 shares of the Company’s common stock. The ending principal balance on this note at December 31, 2018 is $51,005 to the original noteholder. During the year-ended December 31, 2018 the unrelated third-party noteholder converted $3,350 in principal balance into 120,000 shares of the Company’s common stock thereby leaving a principal balance to this unrelated noteholder in the amount of $16,650. Convertible Notes Payable - LG (8%) (Notes 5 & 6) On January 25, 2018 the Company issued a convertible note payable (promissory note) to an investor in the principal amount of $78,750. The note matures on January 25, 2019 and bears interest at 8%. The note holder has has the right at any time on or after the day that is six months from January 25, 2018 to convert any part or all of the outstanding unpaid principal balance into shares of the Company’s common stock. The entire principal balance of $78,750 is outstanding as of December 31, 2018. On June 4, 2018 the Company issued a convertible note payable (promissory note) to an investor in the principal amount of $52,500. The note matures on June 4, 2019 and bears interest at 8%. The note holder has has the right at any time on or after the day that is six months from June 4, 2018 to convert any part or all of the outstanding unpaid principal balance into shares of the Company’s common stock. The entire principal balance of $52,500 is outstanding as of December 31, 2018. Convertible Notes Payable - PULG (8%) (Notes 1 & 2) On October 1, 2018 the Company issued a convertible note payable (convertible promissory note PULG (8%) Note 1) to an investor in the principal amount of $58,000. The note matures on April 1, 2020 and bears interest at 8%. The note holder has has the right at any time on or after the day that is six months from October 1, 2018 to convert any part or all of the outstanding unpaid principal balance into shares of the Company’s common stock. The entire principal balance of $58,000 is outstanding as of December 31, 2018. On November 19, 2018 the Company issued a convertible note payable (convertible promissory note PULG (8%) Note 2) to an investor in the principal amount of $65,000. The note matures on May 19, 2020 and bears interest at 8%. The note holder has has the right at any time on or after the day that is six months from November 19, 2018 to convert any part or all of the outstanding unpaid principal balance into shares of the Company’s common stock. The entire principal balance of $65,000 is outstanding as of December 31, 2018. The Company’s convertible notes payable and the related derivative liabilities, derivative discount, deferred financing costs and original-issue discount are presented in the financial statements at December 31, 2018 as follows: 12/31/2018 Remaining Original Deferred Total Principal Issue Derivative Financing Convertible Derivative Debt Amount Discount Discount Costs Notes Payable Liability Note Payable - BS $ 125 $ 125 Note Payable - SF 60 60 Note Payable - SD 15,000 15,000 Note Payable - NW 715 715 Note Payable - MC #2 890 890 Convertible Note Payable - JR (5%) 45,500 (45,486 ) 14 51,639 Convertible Note Payable - HG (10%) 16,650 16,650 Convertible Note Payable - CB (5%) - - 1,431 Convertible Notes Payable- SO (8%) - - - Convertible Note Payable - LGC (8%) 1 32,660 32,660 15,356 Convertible Note Payable - LGC (8%) 2 125,000 - 125,000 22,713 Convertible Note Payable - LGC (8%) 3 125,000 - - 125,000 22,743 Convertible Note Payable - LGC (8%) 4 125,000 - - 125,000 22,768 Convertible Note Payable - MLM (10%) (Related party) 51,005 - 51,005 28,741 Convertible Note Payable - LGC (8%) 5 78,750 (28,646 ) (462 ) 49,642 8,354 Convertible Note Payable - LGC (8%) 6 52,500 (26,803 ) (808 ) 24,889 16,972 Convertible Notes Payable- PULG (8%) 1 65,000 (63,610 ) (2,244 ) (854 ) 35,933 Convertible Notes Payable- PULG (8%) 2 58,000 (47,690 ) (2,655 ) 7,655 36,818 $ 791,855 $ - $ (212,235 ) $ (6,169 ) $ 573,451 $ 263,468 As of December 31, 2018, the convertible notes payable can be converted into approximately 727,373 shares of common stock.

Derivatives and Fair Value Inst

Derivatives and Fair Value Instruments	12 Months Ended
	Dec. 31, 2018
Derivatives and Fair Value Instruments [Abstract]
DERIVATIVES AND FAIR VALUE INSTRUMENTS	Note 6. DERIVATIVES AND FAIR VALUE INSTRUMENTS The Company applied paragraph 815-10-05-4 of the FASB Accounting Standards Codification to the 5% Convertible Notes Payable issued June 12th 2015 and the 8% Convertible Note payable issued June 25th 2015 and for the 8% Convertible Notes Payable issued January 7, 2016 and March 7, 2016, the 9% Convertible Note payable issued October 1, 2016 the 8% Convertible Notes Payable issued January 25, 2018 and June 4, 2018 and the 8% convertible notes payable issued October 1, 2018 and November 19, 2018. Based on the guidance in paragraph 815-10-05-4 of the FASB Accounting Standards Codification the Company concluded these instruments were required to be accounted for as derivatives on issuance date. The Company records the fair value of the Convertible Notes Payable and certain warrants that are classified as derivatives on issuance date and the fair value changes on each reporting date reflected in the consolidated statements of operations as “Change in Fair Value - derivatives.” These derivative instruments are not designated as hedging instruments under paragraph 815-10-05-4 of the FASB Accounting Standards Codification and are disclosed on the balance sheet under Derivative Liabilities. The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Pricing inputs that are generally unobservable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepayments and other current assets, accounts payable, and accrued expenses, approximate their fair values because of the short maturity of these instruments. The Company’s Level 3 financial liabilities consist of the 5% Convertible Notes Payable issued June 12th 2015 and the 8% Convertible Note payable issued June 25th 2015 and for the 8% Convertible Notes Payable issued January 7, 2016 and March 7, 2016 and May 1, 2017 and June 2, 2017 and July 10, 2017 and August 15, 2017, the 9% Convertible Note payable issued October 1, 2016, The 8% Convertible note payable issued January 25, 2018, the 8% Convertible note payable issued June 4, 2018 and the 8% convertible notes payable issued October 1, 2018 and November 19, 2018 for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. We have valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a valuation consultant, for which management understands the methodologies. These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of issuance and December 31, 2018. The primary assumptions include: projected annual volatility of 145%-240%; the follow-on securities purchase option; the conversion feature as a percentage of Market; automatic/conditional conversions; market price trigger events. As of December 31, 2018 the Company’s derivative financial instruments included: 1) Embedded derivatives associated with certain of the Company’s unsecured convertible notes payable. The Company’s 5% convertible notes payable and 8% convertible notes payable and 9% convertible note payable issued to unrelated investors is a hybrid instrument, which warrants separate accounting as a derivative instrument. The embedded derivative feature has been bifurcated from the debt host contract, referred to as the Derivative Liability, which resulted in a reduction of the initial carrying amount (as unamortized discount) of the Convertible Notes Payable. The unamortized discount is amortized to interest expense using the effective interest method over the life of the Notes. The embedded derivative feature includes the conversion feature within the notes and an early redemption option. The compound embedded derivatives within the convertible notes have been recorded at fair value at the date of issuance; and are marked-to-market each reporting period with changes in fair value recorded to the Company’s statement of operations as Change in fair value of derivative liabilities. The 5% Convertible Note Payable and the 8% Convertible Notes Payable and the 9% convertible note payable are valued at December 31,2018. The following assumptions were used for the valuation of the embedded derivative: - The stock price (prior period reverse split 1,000:1) of $0.12 decreased to $0.0438 in this period (basis for the variable conversion prices) would fluctuate with the Company projected volatility - An event of default for the Convertible Note would occur 0% of the time, increasing 1.00% per month to a maximum of 5.0%; - Alternative financing for the Convertible Note would be initially available to redeem the note 0% of the time and increase monthly by 1% to a maximum of 10%; - Capital raising events (a single financing at 1 month from the valuation date) was previously a factor for the VV Note but are no longer projected. The full reset events projected to occur based on future stock issuance (single event) result in a reset exercise price. -The monthly trading volume would average $458,000 (rounded) as of 12/31/18 and would increase at 5% per month; ownership limits conversion across LG’s notes based on 4.99% with shares outstanding increasing monthly by 1%. - The variable conversion price of 45% to 58% over 3 to 20 trading days would have effective rates of 34.36% to 53.40%; - The Note Holders would automatically convert the notes early (and not hold to maturity) with variable conversion prices and full ratchet resets if the registration was effective and not in default; - The projected annual volatility for each valuation period was based on the historical volatility of the Company in the range 230.9% to 415.0%. The foregoing assumptions are reviewed quarterly and are subject to change based primarily on management’s assessment of the probability of the events described occurring. Accordingly, changes to these assessments could materially affect the valuation. The Company’s derivative liabilities on convertible notes payable are presented at market value in the financial statements at December 31, 2018 as follows: 12/31/2018 Original Derivative Quarter Ended Quarter Ended Ended March 31, Derivative Quarter Ended Quarter Ended Ended June 30, Derivative Quarter Ended Quarter Ended Ended September 30, Derivative Quarter Ended Quarter Ended Ended December 31, Derivative Convertible Derivative Treatment Maturity Principal Note Original Derivative Valuation December 31, March 31, 2018 March 31, 2018 2018 Mark-to- Valuation March 31, June 30, 2018 June 30, 2018 2018 Mark-to- Valuation June 30, September 30, 2018 September 30, 2018 2018 Mark-to- Valuation September 30, December 31, 2018 December 31, 2018 2018 Mark-to- Valuation December 31, Note Date Date Amount Valuation 2017 Issuances Conversions Market 2018 Issuances Conversions Market 2018 Issuances Conversions Market 2018 Issuances Conversions Market 2018 8% Convertible Note Payable-issued 5/2/2016 10/1/2016 5/2/2017 $ 57,750 $ 58,355 $ 24,925 $ (26,745 ) $ 5,123 $ 3,303 $ (665 ) $ 2,638 $ (2,740 ) $ 102 $ - $ - 5 % Convertible Note- Payable -issued 6/12/2015 4/12/2016 1/7/2017 35,863 37,827 $ 832 $ - 305 $ 1,137 (233 ) $ 904 211 $ 1,115 316 $ 1,431 8% Convertible Notes Payable-issued May 1, 2016 10/28/2017 5/1/2018 131,250 103,294 $ 52,989 $ (31,013 ) 8,541 $ 30,517 $ (9,148 ) 17,439 $ 38,808 $ (1,605 ) (11,075 ) $ 26,128 $ (10,591 ) (181 ) $ 15,356 8% Convertible Notes Payable-issued June 7, 2016 12/4/2017 6/7/2018 125,000 90,596 $ 64,458 (14,452 ) $ 50,006 55,818 $ 105,824 (75,201 ) $ 30,623 (7,815 ) $ 22,808 10% Convertible Notes Payable-issued March 8, 2016 9/15/2017 9/8/2018 150,000 167,164 $ 108,682 $ (19,359 ) 23,426 $ 112,749 $ (26,895 ) 44,802 $ 130,656 $ (17,872 ) (70,817 ) $ 41,967 $ (34,169 ) 20,943 $ 28,741 8% Convertible Notes Payable-issued August 15, 2017 4/1/2018 8/15/2018 125,000 108,878 $ - $ - 108,878 (3,760 ) $ 105,118 (74,541 ) $ 30,577 (7,834 ) $ 22,743 8% Convertible Notes Payable-issued July 10, 2017 4/1/2018 7/10/2018 125,000 108,061 $ - $ - 108,061 3,092 $ 111,153 (80,625 ) $ 30,528 (7,855 ) $ 22,673 8% Convertible Notes Payable-issued January 25, 2018 4/1/2018 1/25/2019 78,750 65,896 $ - $ - 65,896 135 $ 66,031 (44,217 ) $ 21,814 (13,460 ) $ 8,354 8% Convertible Notes Payable-issued June 4, 2017 6/4/2018 6/4/2018 52,500 42,755 $ - $ - 42,755 532 $ 43,287 (14,084 ) $ 29,203 (12,231 ) $ 16,972 8% Convertible Notes Payable-issued August 2, 2017 10/1/2018 8/2/2020 50,000 $ 99,234 $ (6,927 ) (40,668 ) $ 51,639 8% Convertible Notes Payable-issued October 1, 2018 10/1/2018 4/1/2020 58,000 $ 49,952 (13,134 ) $ 36,818 8% Convertible Notes Payable-issued November 19, 2018 11/19/2018 5/19/2020 65,000 $ 66,134 (30,201 ) $ 35,933 $ 1,054,113 $ 782,826 $ 251,886 $ - $ (77,117 ) $ 22,943 $ 197,712 $ 325,590 $ (36,043 ) $ 117,160 $ 604,419 $ - $ (22,217 ) $ (370,247 ) $ 211,955 $ 215,320 $ (51,687 ) $ (112,120 ) $ 263,468 The Company’s mark-to-market fair value adjustment ((income)/expense) for the year ended December 31, 2018 totaled ($342,264) as follows: Mark-to market fair value adjustment for the quarter ended March 31, 2018 $ 22,943 Mark-to market fair value adjustment for the quarter ended June 30, 2018 117,160 Mark-to market fair value adjustment for the quarter ended September 30, 2018 (370,247 ) Mark-to market fair value adjustment for the quarter ended December 31, 2018 (112,120 ) Total mark-to market fair value adjustment for the year ended December 31, 2018 $ (342,264 )

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2018
Stockholders' Equity [Abstract]
STOCKHOLDERS' EQUITY	Note 7. STOCKHOLDERS’ EQUITY Effective July 23, 2018, the Company effected a 1-for-1,000 reverse stock split of its issued and outstanding common stock. The number of shares of common stock issued and outstanding post- reverse stock split is 1,404,073. All fractional shares have been rounded up to the next whole share. There is no reduction in the number of the Company’s shareholders of record. Unless otherwise noted, impacted amounts and share information included in the financial statements and notes thereto have been retroactively adjusted for the reverse stock split as if such reverse stock split occurred on the first day of the first period presented. As a result of the aforementioned reverse stock split, additional paid-in-capital was increased by $140,169 and $84,861 as of December 31, 2018 and December 31, 2017 respectively on the balance sheet with a corresponding decrease in the par value of common stock issued as of the same dates. The Company has authorized 4,000,000,000 shares of common stock with a par value of $0.0001 per share. Effective September 19, 2017, the Company amended its Articles of Incorporation to increase its authorized Common Stock to 4,000,000,000 shares. There were 3,482,840 and 849,437 shares of common stock issued and outstanding at December 31, 2018 and December 31, 2017, respectively. The Company has authorized 1,000,000 shares of Series A preferred stock with a par value of $0.0001 per share. At December 31, 2018 and December 31, 2017, there were 500,000 shares of Series A preferred stock issued and outstanding respectively. The preferred stock has preferential voting rights of 2,000 votes per outstanding share. The Company has authorized 50,000 shares of Series B convertible preferred stock with a par value of $0.0001 per share. At December 31, 2016 there were 39,000 shares issued of which 12,900 shares of Series B preferred were converted into common stock in accordance with the terms of the Series B Preferred stock. Therefore; there were 26,100 shares outstanding at December 31, 2016. The Series B preferred stock has no voting rights. During the quarter ended March 31, 2017, 18,100 shares of Series B preferred shares were converted into common stock in accordance with the terms of the Series B preferred stock. As of result there were 8,000 shares of Series B preferred shares outstanding at December 31, 2018. The holders of the Series B convertible preferred stock have the right to convert the same into Common Stock of the Corporation at the ratio of one (1) share of Series B Convertible Preferred for five hundred (500) shares of Common Stock. On October 12, 2018, the Company filed with the State of Nevada a certificate of designation pursuant to which the Company designated a new class of preferred stock as the Company’s Series C Convertible Preferred Stock (“Series C Preferred”) having a $100.00 stated value per share (“Stated Value”) and a par value equal to $0.0001 per share. The Company designated 5,000 shares of Series C Preferred. Subject to a beneficial ownership limitation equal to 4.99% and a prohibition on conversions within the first sixty days of its issuance, each share of Series C Preferred is convertible into 25,000 shares of the Company’s common stock. Holders of Series C Preferred are not entitled to receive dividends. In the event of any liquidation, dissolution or winding up of the Company, holders of Series C Preferred are entitled to distributions from the assets in an amount equal to, or if less, on a prorated basis, the Stated Value per share of Series C Preferred held by such holders. Holders of Series C Preferred are entitled to vote, on an as-converted basis, together with holders of Common Stock on all actions to be taken by the shareholder of the Company. During the quarter-ended December 31, 2018 the company issued 177 shares of Series C Convertible Preferred Stock for services provided to the company by various professionals. As of December 31, 2018 there are 177 shares issued and outstanding with a stated value of $17,700 and par value of $-0-. The preferred shares issued to professionals for their services were valued, in total, at $204,212 based upon a valuation using the underlying convertible feature of the company’s common stock and a Black-Scholes calculation methodology. The fair value of each issuance of Series C Preferred Stock on the date of issuance is estimated using the Black-Scholes option-pricing model reflecting the following assumptions: Expected volatility 403% to 435% Expected life 0.7 Risk free interest rate 2.75% Dividend yield 0.00% During the quarter ended March 31, 2017, the Company issued an aggregate 43,000 shares of common stock at prices ranging from $0.0028 to $0.0094 per share for services provided to the Company. During the quarter ended March 31, 2017, the Company issued an aggregate 112,498 shares of common stock at prices ranging from $0.0001 to $0.0028 per share as partial conversion of notes. During the quarter ended March 31, 2017, the Company issued an aggregate 9,050 shares of common stock for conversion of 18,100 shares of Preferred Series B stock. During the quarter ended June 30, 2017, the Company issued an aggregate 33,000 shares of common stock at prices ranging from $0.0022 to $0.0028 per share for services provided to the Company. During the quarter ended June 30, 2017, the Company issued an aggregate 177,072 shares of common stock at prices ranging from $0.0001 to $0.0028 per share as partial conversion of notes and accrued interest. During the quarter ended June 30, 2017, the Company issued an aggregate 450,000 shares of Preferred Series A stock at par of $.0001. During the quarter ended September 30, 2017, the Company issued an aggregate 41,000 shares of common stock at prices ranging from $0.0002 to $0.0021 per share for services provided to the Company. During the quarter ended September 30, 2017, the Company issued an aggregate 62,196 shares of common stock at prices ranging from $0.00065 to $0.00099 per share as partial conversion of notes and accrued interest. During the quarter ended December 31, 2017, the Company issued an aggregate 71,000 shares of common stock at prices ranging from $0.0006 to $0.0011 per share for services provided to the Company. During the quarter ended December 31, 2017, the Company issued an aggregate 74,772 shares of common stock at prices ranging from $0.0004 to $0.0006 per share as partial conversion of notes and accrued interest. During the quarter ended March 31, 2018, the Company issued an aggregate 18,000 shares of common stock at prices ranging from $0.0006 to $0.0011 per share for services provided to the Company. During the quarter ended March 31, 2018, the Company issued an aggregate 376,111 shares of common stock at prices ranging from $0.0004 to $0.0006 per share as partial conversion of notes and accrued interest. During the quarter ended June 30, 2018, the Company issued an aggregate 67,500 shares of common stock at prices ranging from $0.0004 to $0.0004 per share for services provided to the Company. During the quarter ended June 30, 2018, the Company issued an aggregate 92,015 shares of common stock at prices ranging from $0.000174 to $0.00025 per share as partial conversion of notes and accrued interest. During the quarter ended September 30, 2018, the Company issued an aggregate 634,053 shares of common stock at prices ranging from $0.0525 to $0.18 per share for services provided to the Company. During the quarter ended September 30, 2018, the Company issued an aggregate 427,755 shares of common stock at prices ranging from $0.0190 to $0.1173 per share as partial conversion of notes and accrued interest. During the quarter ended December, 2018, the Company issued an aggregate 1,017,959 shares of common stock at prices ranging from $0.019 to $0.025 per share as partial conversion of notes and accrued interest.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2018
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	Note 8. COMMITMENTS AND CONTINGENCIES The Company currently has three office locations. It rents offices on a month-to-month basis from the Company’s President and stockholder for $525 per month which amounted to $6,300 for the year ended December 31, 2018. The Company also has ready-to-go office space available to be used for meetings etc. at a nominal cost of approximately $100 per month with no commitment. The cost of this space for the year ended December 31, 2018 was $1,188. On September 12th 2016 the Company entered into a commercial lease agreement for office premises at an original cost of $650 per month for a one-year term with the option to renew for one extended term of three years. In July 2017 the Company leased additional space at this location thereby increasing the monthly rent to $1,550. The cost of this space for the year ended December 31, 2018 was $23,442. A new lease was signed in March 2018 for the same space. The following are the minimum required lease payments under the lease for the next three years: 2019 24,600 2020 24,600 2021 4,100 Total rent expense for the year ended December 31, 2018 and 2017 was $30,929 and $20,713 respectively. The Company has a distribution agreement with Dr. Ronald L. Rubin where upon any sales generated by him he will receive the following commissions: ● 20% for direct sales ● 5% for any sale that he oversees that involves another sales person ● 5% for any sales related to a distribution agreement. ● He is to be issued 1 Series C Preferred share or 25,000 common shares per month The Company has a distribution agreement with Dr. Gupta Pharma LLC with the following provisions: ● The Company, via its subsidiary USA Pharma, has exclusive New Jersey distribution rights for all CBD products and non-exclusive rights to all other territories. ● The agreement is for a term of 3 years, but parties have the right to terminate. ● Upon agreement signing, 120 shares of Series C Convertible Preferred stock was issued by the Company to Dr. Gupta. ● Dr. Gupta shall have 30% of the issued and outstanding common stock of the Company during the term of this agreement. Should the percentage of ownership drop below 30% then the Company must issue additional Series C Convertible Preferred Shares which are convertible into the required additional amount of common stock minus 3,000,000 shares of common stock.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2018
Income Taxes [Abstract]
INCOME TAXES	Note 9. INCOME TAXES On December 22, 2017, the President signed into law the Tax Cuts and Jobs Act (H.R. 1) (the “Act”). The Act includes a number of changes in existing tax law impacting businesses including, among other things, a permanent reduction in the corporate income tax rate from 34% to 21%. The rate reduction would take effect on January 1, 2018. As of December 31, 2016, the Company had net deferred tax assets consisting primarily of net operating losses totaling $484,037 that were fully reserved. Under U.S. generally accepted accounting principles, the Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company’s net deferred tax asset as of December 31, 2016 was determined based on the current enacted federal tax rate of 34% prior to the passage of the Act. As a result of the reduction in the corporate income tax rate to 21% from 34% under the Act, the Company revalued its December 31, 2016 net deferred tax asset as of December 31, 2017. The Company reduced the value of its net deferred tax asset by approximately $146,337, which, since it is fully reserved, was not recorded as an additional income tax expense in the Company’s statement of operations in the fourth quarter of 2017. The Company’s deferred tax asset consists primarily of carryforward net operating losses (NOLs). The Company believes that, at this time, it is more likely than not that the benefit of the NOLs will not be realized and has therefore recorded a full valuation allowance. The following represents the tax NOLs incurred by the Company on a per year basis and the resulting estimated deferred tax asset and valuation allowance: Year Ended December 31, Net Estimated 2010 $ 4,457 $ 1,337 2011 34,325 $ 10,298 2012 174,024 $ 52,207 2013 114,267 $ 34,280 2014 294,880 $ 88,464 2015 121,619 $ 36,486 2016 382,095 $ 114,629 2017 1,148,020 $ 344,406 2018 629,038 $ 188,711 Total $ 2,902,725 $ 870,818 Less: Valuation Allowance $ (870,818 ) Net Deferred Tax Asset $ - The income tax benefit differs from the amount computed by applying the statutory federal and state income tax rates to the loss before income taxes. The sources and tax effects of the differences are as follows: December 31, December 31, 2018 2017 Statutory federal income tax rate 21 % 21 % State income taxes, net of federal taxes 9 % 9 % Valuation allowance (30 )% (30 )% Effective income tax rate 0 % 0 % As of December 31, 2018, the Company has a net operating loss carryforward of approximately $2,902,725 to reduce future federal taxable income which begins to expire in the year 2030. The Company is also subject to corporate taxes in the State of New Jersey which has similar net operating loss carryover provisions which start to expire in the year 2030. Under the current Tax Cuts and Jobs Act (H.R. 1) (the “Act”), federal net operating losses generated after December 31, 2017 can be carried forward indefinitely but only 80% of taxable income can be offset with a net-operating loss deduction. Net operating losses generated in years 2017 and prior may be fully utilized up to 100% of taxable income and they still maintain their 20-year carry-forward life. The Company currently has no federal or state tax examinations in progress, nor has it had any federal or state examinations since its inception. All of the Company’s open tax years beginning in tax year 2014 are subject to federal and state tax examinations.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2018
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	Note 10. RELATED PARTY TRANSACTIONS As more fully described in Notes 3 and 4 to the Consolidated Financial Statements, the Company owed the following amounts to related parties as of the following: December 31, December 31 2018 2017 Due to Related Party $ 8,921 $ 8,921 Due to officer/stockholder 8,955 8,398 Due to other stockholders 3,100 6,790 Total Related Party Obligations $ 20,976 $ 24,109 The company has entered into an employment agreement with its Chief Executive Officer (CEO) for the five year period beginning January 1, 2012. The agreement provides for base compensation, annual bonus, benefits, vacation and reimbursements. Under this agreement, the base compensation of the Company’s CEO is $100,000 per annum which has been accrued for the years ended December 31, 2015 and 2014. In mid-year 2016 the Company commenced payroll and is paying the CEO for current wages in this manner. During the year ended December 31, 2016, $18,974 in accrued compensation was paid. Accrued compensation in the amount of $30,000 was converted to shares of common stock during 2015. In the quarter ended June 30, 2017, $45 in accrued CEO compensation was converted to Series A Preferred shares. During the quarter ended September 30, 2017, $25,500 in accrued compensation was paid to the CEO. Effective October 1, 2017, the employment agreement between the Company and its CEO was amended to increase the annual salary to $150,000. During the quarter ended December 31, 2017 $44,673 in accrued compensation was paid to the CEO. As of December 31, 2018, the company owes accrued compensation to it’s CEO in the amount of $388,981. As more fully described in Note 1-Intangible Asset-Licensing Agreement, on March 8th 2016 (with an effective date of October 1, 2015) the Company entered into a Licensing Agreement with a Florida Corporation (Licensor) that is owned by a related party. The Company issued 25,000 shares of Series B Preferred stock to the Licensor as partial consideration for the Licensing agreement plus a $150,000 promissory note to the Licensor for the balance of the consideration. During the quarter-ended March 31, 2016, 3,400 shares of Series B Preferred stock were converted into 1,700 shares of common stock in accordance with the terms of the Series B Preferred stock. During the quarter ended March 31, 2017, 18,100 shares of Series B preferred stock was converted into 9,050 shares of common stock in accordance with the terms of the Series B Preferred stock. As more fully described in Note 1 and Note 5 to the financial statements, $18,986 in accrued interest on the $150,000 note was satisfied through the issuance of 17,273 shares of the Company’s common stock. On September 15, 2017 the Note was amended to include provisions to allow conversion of the Note into common stock of the Company. At such time the Note was valued with its embedded derivative and discount. On September 25, 2017, $16,250 in principal on this note was satisfied by the conversion into 25,000 shares of the Company’s common stock. During the quarter ended March 31, 2018, $15,000 in principal on this note was satisfied by the conversion into 60,000 shares of the Company’s common stock. During the quarter ended June 30, 2018, $7,500 in principal on this note was satisfied by the conversion into 30,000 shares of the Company’s common stock. During the quarter ended June 30, 2018 the original related-party noteholder sold $20,000 in principal on this note to an unrelated third party investor thereby leaving $80,250 in principal balance due to the related party original noteholder and $20,000 in principal due to the unrelated third-party investor. During the year ended December 31, 2018 the Company made cash paydowns to the noteholder in the total amount of $32,550. In addition, $30,195 in principal balance on the note was converted into 495,000 shares of the Company’s common stock. The ending principal balance on this note at December 31, 2018 is $51,005 to the original noteholder. During the year-ended December 31, 2018 the unrelated third-party noteholder converted $3,350 in principal balance into 120,000 shares of the Company’s common stock thereby leaving a principal balance to this unrelated noteholder in the amount of $16,650.

Basis of Reporting - Going Conc

Basis of Reporting - Going Concern	12 Months Ended
	Dec. 31, 2018
Basis of Reporting - Going Concern [Abstract]
BASIS OF REPORTING - GOING CONCERN	Note 11. BASIS OF REPORTING - GOING CONCERN The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses from inception of approximately $4,633,720 which, among other factors, raises substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon management’s plans to raise additional capital from the sale of stock and to receive additional financing and to commence sales of its flagship product and create revenue. The accompanying financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern. Management believes the Company’s present cash and cash equivalents will not enable it to meet its obligations for twelve months from the date these financial statements are available to be issued unless the Company received additional funding.

Stock Compensation - Equity Inc

Stock Compensation - Equity Incentive Plan	12 Months Ended
	Dec. 31, 2018
Stock Compensation - Equity Incentive Plan [Abstract]
STOCK COMPENSATION - EQUITY INCENTIVE PLAN	Note 12. STOCK COMPENSATION - EQUITY INCENTIVE PLAN In July 2016, the Company adopted the Medifirst Solutions, Inc. 2016 Equity Incentive Plan (the “Plan”) pursuant to which the Company may grant stock options, restricted stock purchase offers and other equity-based awards up to an aggregate of 20,000,000 shares of common stock. The Plan is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Participants with a proprietary interest in the growth and performance of the Company. On December 6th, 2016 the company amended the terms of the Plan and filed an S-8 Registration Statement with the Securities and Exchange Commission (“SEC”) increasing the number of shares permitted to be issued under the Plan to 32,000. During the quarter ended March 31, 2017, the Company issued from the Plan a total of 27,100 shares of common stock to non-employees for services rendered. As of March 31, 2017 there is a balance of -0- shares available for future issuance under the Medifirst Solutions, Inc. 2016 Equity Incentive Plan. In May 2017, the Company adopted the Medifirst Solutions, Inc. 2017 Equity Incentive Plan (the “2017 Plan”) pursuant to which the Company may grant stock options, restricted stock purchase offers and other equity-based awards up to an aggregate of 125,000 shares of common stock. The Plan is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Participants with a proprietary interest in the growth and performance of the Company. During the year ended December 31, 2017, the Company issued from the Plan 108,000 shares to non-employees for services rendered. As of December 31, 2017 there is a balance of 17,000 shares available for future issuance under the Medifirst Solutions, Inc. 2017 Equity Incentive Plan. In January 2018, the Company adopted the Medifirst Solutions, Inc. 2018 Equity Incentive Plan (the “2018 Plan”) pursuant to which the Company may grant stock options, restricted stock purchase offers and other equity-based awards up to an aggregate of 175,000 shares of common stock. The Plan is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Participants with a proprietary interest in the growth and performance of the Company. During the quarter ended March 31, 2018, the Company issued from the 2018 Plan a total of 4,000 shares of common stock to non-employees for services rendered. As of March 31, 2018 there is a balance of 188,000 shares available for future issuance under the Medifirst Solutions, Inc. 2018 Equity Incentive Plan. During the quarter ended June 30, 2018, the Company issued from the 2018 Plan a total of 17,500 shares of common stock to non-employees for services rendered. As of June 30, 2018 there is a balance of 170,500 shares available for future issuance under the Medifirst Solutions, Inc. 2018 Equity Incentive Plan. During the quarter ended September 30, 2018, there were no issuances from the 2018 Plan and therefore as of September 30, 2018 there is a balance of 170,500 shares available for future issuance under the Medifirst Solutions, Inc. 2018 Equity Incentive Plan. During the quarter ended December 30, 2018, there were no issuances from the 2018 Plan and therefore as of December 31, 2018 there is a balance of 170,500 shares available for future issuance under the Medifirst Solutions, Inc. 2018 Equity Incentive Plan.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2018
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	Note 13. SUBSEQUENT EVENTS The Company has evaluated subsequent events through the date which the consolidated financial statements were issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the consolidated financial statements, except as disclosed. Subsequent to the year ended December 31, 2018 the Company issued an aggregate 2,049,043 shares of Common Stock upon conversions of an aggregate principal amount equal to $34,038 outstanding convertible promissory notes and $2,977 in accrued interest. Subsequent to the year ended December 31, 2018 the Company issued an aggregate 277,000 shares of Common Stock to consultants for services performed. These 277,000 shares were issued under the Company’s 2019 Equity Incentive Plan. Subsequent to the year ended December 31, 2018 the Company issued an aggregate 52 shares of Series C Convertible Preferred Stock to consultants for services performed. These 52 shares of Series C Convertible Preferred Stock are convertible into 1,550,000 shares of common stock of the Company. These 52 shares of Series C Convertible Preferred Stock will be recorded on the Company’s books at fair value using a Black-Scholes pricing model. On January 24, 2019, the Company entered into a Securities Purchase Agreement with an investor to issue a convertible promissory note in the amount of $43,000. The note pays 12% interest per annum and matures on November 15, 2019. After six months from the date of the note, the investor may convert the principal balance into common stock of the Company. On January 28, 2019 the cash funding was received by the Company and the convertible note was issued. On February 4, 2019, the Company entered into a Securities Purchase Agreement with an investor to issue a convertible promissory note in the amount of $38,000. The note pays 12% interest per annum and matures on November 30, 2019. After six months from the date of the note, the investor may convert the principal balance into common stock of the Company. On February 6, 2019 the cash funding was received by the Company and the convertible note was issued. On February 20, 2019, the Company entered into a Securities Purchase Agreement with an investor to issue a convertible promissory note in the amount of $54,000. The note pays 8% interest per annum and matures on August 20, 2019. At any time after the date of the note, the investor may convert the principal balance of the note into common stock of the Company. On February 21, 2019 the cash funding was received by the Company and the convertible note was issued to the investor. On February 25, 2019, the Company entered into a Securities Purchase Agreement with an investor to issue a convertible promissory note in the amount of $65,000. The note pays 12% interest per annum and matures on February 25, 2020. At any time after six months from the date of the note, the investor may convert the principal balance of the note into common stock of the Company. On February 26, 2019 the cash funding was received by the Company and the convertible note was issued to the investor. On February 27, 2019, the Company entered into a Securities Purchase Agreement with an investor to issue a convertible promissory note in the amount of $154,500. The note pays 8% interest per annum and contains a $15,000 original issue discount (OID). The note is to be funded in two tranches. After funding of the initial tranche, the principal balance of the note will be $51,500 which includes the first tranche of $46,500 and $,5000 of pro-rated OID. The maturity date for each tranche shall be 18 months from the effective date of each tranche payment. At any time after the date of the note, the investor may convert the principal balance of the note into common stock of the Company. On March 1, 2019 the cash funding for the initial tranche was received by the Company and the convertible note issued to the investor. On March 8, 2019, the Company issued sixty (60) shares of the Company’s Series C Convertible Preferred Stock to the Company’s Chief Executive Officer. Each share of Series C Preferred has a $100.00 stated value per share. Subject to a beneficial ownership limitation equal to 4.99% and a prohibition on conversions within the first sixty days of its issuance, each share of Series C Preferred is convertible into 25,000 shares of the Company’s common stock. Holders of Series C Preferred are not entitled to receive dividends. In the event of any liquidation, dissolution or winding up of the Company, holders of Series C Preferred are entitled to distributions from the assets in an amount equal to, or if less, on a prorated basis, the Stated Value per share of Series C Preferred held by such holders. Holders of Series C Preferred are entitled to vote, on an as-converted basis, together with holders of Common Stock on all actions to be taken by the shareholders of the Company. Subsequent to the year ended December 31, 2018 the Company created the Medifirst Solutions, Inc. 2019 Equity Incentive Plan which is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Participants with a proprietary interest in the growth and performance of the Company. The total number of shares of Common Stock which may be purchased or granted directly by Options, Stock Awards or Restricted Stock Purchase Offers, or purchased indirectly through exercise of Options granted under the Plan shall not exceed Five Million (5,000,000). Subsequent to the year end, the Company issued 277,000 shares under this plan. On March 7, 2019, the Company entered into a Distribution Agreement with a company based in Guatemala City, Guatemala, Central America to distribute its products(s) on a non-exclusive basis throughout Latin America. The term of this agreement is for three years and shall automatically renew for successive three year periods unless either party notifies the other, in writing, that they do not desire renewal.

Nature of Operations and Summ_2

Nature of Operations and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2018
Nature of Operations and Summary of Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). In the opinion of management, all adjustments considered necessary for a fair presentation of the consolidated financial statements have been included. All such adjustments are of a normal recurring nature. The consolidated financial statements include the accounts of Medifirst Solutions Inc. and its wholly owned subsidiaries (Medical Laser Manufactures, Inc. and Concierge Concepts Rx) and its majority owned subsidiary (USA Pharma Corporation) (collectively referred to as the “Company”). All material intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the consolidated financial position of the Company as of December 31, 2018 and 2017, the consolidated results of its operations for the years ended December 31, 2017 and 2018, and the consolidated cash flows for the years ended December 31, 2018 and 2017. Some items in the prior year financial statements were reclassified to conform to the current presentation. Reclassifications had no effect on prior year net income or shareholders’ equity. Effective July 23, 2018, the Company effected a 1-for-1,000 reverse stock split of its issued and outstanding common stock. The number of shares of common stock issued and outstanding post- reverse stock split is 1,404,073. All fractional shares have been rounded up to the next whole share. There is no reduction in the number of the Company’s shareholders of record. Unless otherwise noted, impacted amounts and share information included in the financial statements and notes thereto have been retroactively adjusted for the reverse stock split as if such reverse stock split occurred on the first day of the first period presented.
Revenue Recognition	Revenue Recognition In general, the Company follows ASC 605 and records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. The following policies reflect specific criteria for the various revenues streams of the Company: Revenue is recognized at the time the product is delivered or services are performed. Provision for sales returns are estimated based on the Company’s historical return experience. Revenue is presented net of returns. The Company also derives consulting revenue from its CCRx division. Such revenue is recognized at the time services are performed.
Accounts Receivable	Accounts Receivable The Company extends credit to its customers in the normal course of business and performs ongoing credit evaluations of its customers, maintaining an allowance for potential credit losses. Accounts receivable is reported net of the allowance for doubtful accounts. The allowance is based on management’s estimate of the amount of receivables that will actually be collected. The Company has not recorded an allowance for doubtful accounts as of December 31, 2018 or 2017. There are no customer account receivables as of December 31, 2018 or 2017.
Inventory	Inventory Inventory consists of finished goods and is stated at the lower of cost (first-in, first-out) or market value. Finished goods inventory includes hand held laser devices, their carrying cases and goggles.
Equipment	Equipment Equipment, consisting of computer equipment, is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, of five years.
Long-Lived Assets	Long-Lived Assets The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds the estimated future cash flows, an impairment loss will be recorded by the amount the carrying value exceeds the fair value of the asset.
Intangible Asset- Licensing Agreement	Intangible Asset- Licensing Agreement On March 8th 2016 (with an effective date of October 1, 2015), the company, through its wholly-owned subsidiary (“Licensee”), entered into a Product and Know-How License Agreement (“Agreement”) with a Florida Corporation (“Licensor”) which is owned by a related party - the son of the Company’s CEO to license certain laser technology (the “Technology”). The license provides an irrevocable, nontransferable, royalty-bearing license, with a right of sublicense with respect to the Technology (the “License”), throughout the Territory in the Field of Use, whether or not under the Licensed Patent, to: - use or submit or deliver the Technology and/or any Product to any regulatory body throughout the Territory for purposes of obtaining approval to make, Sell, offer for Sale, import, export and distribute the Technology or Products; and - use or submit or deliver the Technology and/or any Product to any regulatory body throughout the Territory for purposes of obtaining approval to make, Sell, offer for Sale, import, export and distribute the Technology or Products; and - use or copy the Technology and/or any Product; and - market, make, have made, Sell, offer for Sale, import and distribute Products; and - sublicense the Technology; and - prepare, or have prepared on its behalf, modifications, enhancements and/or derivative works of the Technology. In connection with the license granted, Licensor hereby grants to Licensee a license to the Licensed Patents, whether now existing or hereafter acquired. The consideration for the licensing agreement consisted of the issuance of 25,000 Series B Preferred stock shares to the Licensor (at par) plus a $150,000 promissory note issued by the Company to the licensor. On September 15, 2017 the Note was amended to include provisions to allow conversion of the Note into common stock of the Company. On September 25, 2017, $16,250 in principal on this note was satisfied by the conversion into 25,000,000 shares of the Company’s common stock. During the quarter ended June 30, 2018, the original noteholder assigned $20,000 in principal to an unrelated third-party. The principal balance on this note as of December 31, 2018 is $51,005 to the original noteholder and $16,650 in principal balance to the new unrelated third-party noteholder. There were $32,550 in cash principal paydowns to the original noteholder during the year ended December 31, 2018. There were an additional $33,345 in conversions to common stock that took place on these two notes during the year ended December 31, 2018. The last part of the consideration in this license agreement is the royalty payments which have not taken effect yet since they are based on sales for which the company has had only minimum thus far. The licensing agreement is for a ten year period effective from October 1, 2015. The cost of the licensing agreement is being amortized over it’s ten-year period and charged to income on a straight-line basis.
Product Warranty	Product Warranty We generally provide a one-year warranty on our products. Currently no material evaluations or studies have been performed to obtain warranty data since there are so few sold products outstanding. As sales increase, the Company will estimate future warranty costs from historical data and trends of product reliability and costs of repairing and replacing defective products.
Debt Issue Costs and Debt Discount	Debt Issue Costs and Debt Discount The Company may pay debt issue costs, and record debt discounts in connection with raising funds through the issuance of convertible debt. These costs are amortized over the life of the debt to interest expense. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts are immediately expensed. Beginning in 2015, the Company adopted ASU 2015-03: Simplifying the Presentation of Debt Issuance Costs and has reflected the deferred financing costs as a direct reduction of the related debt (See table included in Note 5 to Consolidated Financial Statements).
Original Issue Discount	Original Issue Discount For certain convertible debt issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt.
Derivative Liabilities	Derivative Liabilities Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. The Company assessed its securities for purposes of determining the proper accounting treatment and valuation as set forth in the Statement of Financial Accounting Standard ASC 820–10–35–37 Fair Value in Financial Instruments Accounting for Derivative Instruments and Hedging Activities In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments. Once the derivative liabilities are determined, they are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the condensed consolidated balance sheets and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.
Financial Instruments	Financial Instruments The carrying amounts reported in the balance sheets for cash, accounts receivable, accounts payable, and other accrued liabilities approximate their fair values.
Segment Information	Segment Information The Company follows Accounting Standards Codification (“ASC”) 280, “Segment Reporting”. The Company currently operates in a single segment and will evaluate additional segment disclosure requirements as it expands its operations.
Net Income (Loss) Per Common Share	Net Income (Loss) Per Common Share The Company calculates net income (loss) per share based on the authoritative guidance. Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares and dilutive common stock equivalents outstanding. During periods in which the Company incurs losses, common stock equivalents, if any, are not considered, as their effect would be anti-dilutive. As described in Note 5 to the financial statements, as of December 31, 2018, convertible debt can be converted into approximately 727,323 shares of common stock.
Income Taxes	Income Taxes The Company utilizes the accrual method of accounting for income taxes. Under the accrual method, deferred tax assets and liabilities are determined based on the differences between the financial reporting basis and the tax basis of the assets and liabilities, and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. An allowance against deferred tax assets is recognized, when it is more likely than not, that such tax benefits will not be realized. The Company recognizes the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount recognized in the financial statements is the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the threshold, no financial statement benefit is recognized. The Company recognizes interest and penalties, if any, related to uncertain tax positions in income tax expense. The Company did not have any unrecognized tax benefits as of December 31, 2018, and does not expect this to change significantly over the next 12 months.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for equity instruments issued to employees in accordance with ASC 718, Compensation - Stock Compensation. ASC 718 requires all share-based compensation payments to be recognized in the financial statements based on the fair value on the issuance date. Equity instruments granted to non-employees are accounted for in accordance with ASC 505, Equity. The final measurement date for the fair value of equity instruments with performance criteria is the date that each performance commitment for such equity instrument is satisfied or there is a significant disincentive for non-performance.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At December 31, 2018, the Company had $83,387 in cash equivalents.
Recent Pronouncements	Recent Pronouncements In May 2014, FASB and IASB issued a new joint revenue recognition standard that supersedes nearly all GAAP guidance on revenue recognition. The core principle of the standard is that revenue recognition should depict the transfer of goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard is effective for the Company to annual reporting periods beginning after December 15, 2017 (that is, a public organization is required to apply the new revenue standard beginning in the first interim period within the year of adoption). Additionally, the Board decided to permit public organizations to adopt the new revenue standard early, but not before the original public organization effective date (that is, annual periods beginning after December 15, 2016). A public organization should apply the new revenue standard to all interim reporting periods within the year of adoption. The Company has evaluated the impact of this ASU on the consolidated financial statements and has determined, at this time, the ASU’s implementation would not have a material impact on revenue recognition. See below - Accounting Standards Update 2016-10 - Revenue from Contracts with Customers (Topic 606) Identifying Performance Obligations and Licensing In June 2018, the FASB issued Accounting Standards Update 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). ASU 2018-07 expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 also clarifies that Topic 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Revenue from Contracts with Customers (Topic 606). ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company will adopt the provisions of ASU 2018-07 in the quarter beginning January 1, 2019. The adoption of ASU 2018-07 is not expected to have any impact on the Company’s financial statement presentation or disclosures. The Company does not plan to have any equity instruments that will need revaluation under this new standard. In April 2016, the FASB issued Accounting Standards Update 2016-10 - Revenue from Contracts with Customers (Topic 606) Identifying Performance Obligations and Licensing. The core principle of the guidance in Topic 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps: 1. Identify the contract(s) with a customer. 2. Identify the performance obligations in the contract. 3. Determine the transaction price. 4. Allocate the transaction price to the performance obligations in the contract. 5. Recognize revenue when (or as) the entity satisfies a performance obligation. The amendments in this Update do not change the core principle of the guidance in Topic 606. Rather, the amendments in this Update clarify the following two aspects of Topic 606: identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas. The Company is currently evaluating the impact of this ASU on the consolidated financial statements. In February 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220)”. The objective of the ASU is to allow a reclassification from accumulated comprehensive income (loss) to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act and will improve the usefulness of information reported to financial statement users. This ASU is effective for interim and annual reporting periods beginning after December 15, 2018, and early adoption is permitted. The Company is currently evaluating the impact of this ASU on the consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, “Leases” (Topic 842), in order to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet for those leases classified as operating leases under previous GAAP. ASU 2016-02 requires that a lessee should recognize a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term on the balance sheet. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 (including interim periods within those periods) using a modified retrospective approach and early adoption is permitted. The Company will adopt ASU 2016-02 in the first quarter of 2019. A modified retrospective transition approach is required, applying the new standard to all leases existing at the date of initial application. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. If an entity chooses the second option, the transition requirements for existing leases also apply to leases entered into between the date of initial application and the effective date. The entity must also recast its comparative period financial statements and provide the disclosures required by the new standard for the comparative periods. The Company will adopt the new standard on January 1, 2019 and use the effective date of initial application. Consequently, financial information will not be updated and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company expects to elect the “package of expedients”, which permits the Company not to reassess under the new standard the Company’s prior conclusions about lease identification and initial direct costs. The Company does not expect to elect the use-of hindsight or the practical expedient pertaining to land easements, the latter not being applicable to the Company. The new standard also provides practical expedients for the Company’s ongoing accounting. The Company currently expects to elect the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, the Company will not recognize ROU assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets in transition. The Company also expects to elect the practical expedient to not separate lease and non-lease components for all of its leases other than leases of real estate. The Company expects the most significant change will be related to the recognition of right-of-use assets and lease liabilities on the Company’s balance sheet for real estate operating leases. The Company is currently in the process of evaluating the impact of ASU 2016-02 on the Company’s outstanding leases. The Company has not yet determined, as a result of the adoption of this guidance, how much right-of-use assets and lease liabilities will be recorded. The Company also expects that the adoption of this guidance will result in additional lease-related disclosures in the footnotes to its consolidated financial statements. During the fiscal year ended December 31, 2018, Company was an “emerging growth company” as defined in Section 2(a)(19) of the Securities Act and the extended transition period applies to all aforementioned ASUs, until such time as the Company is no longer an “emerging growth company”. However, as of January 1, 2019, the Company no longer meets the definition of an “emerging growth company” and for periods subsequent to December 31, 2018, the Company will cease to take advantage of the extended transition period applied to such ASUs.

Property, Plant and Equipment_2

Property, Plant and Equipment (Net) (Tables)	12 Months Ended
	Dec. 31, 2018
Property, Plant and Equipment (Net) [Abstract]
Summary of equipment recorded at cost	December 31, 2018 December 31, 2017 Computer equipment $ 8,956 $ 8,956 Less: accumulated depreciation (8,365 ) (7,725 ) $ 592 $ 1,232

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2018
Short-term Debt [Line Items]
Schedule of derivative liabilities	12/31/2018 Remaining Original Deferred Total Principal Issue Derivative Financing Convertible Derivative Debt Amount Discount Discount Costs Notes Payable Liability Note Payable - BS $ 125 $ 125 Note Payable - SF 60 60 Note Payable - SD 15,000 15,000 Note Payable - NW 715 715 Note Payable - MC #2 890 890 Convertible Note Payable - JR (5%) 45,500 (45,486 ) 14 51,639 Convertible Note Payable - HG (10%) 16,650 16,650 Convertible Note Payable - CB (5%) - - 1,431 Convertible Notes Payable- SO (8%) - - - Convertible Note Payable - LGC (8%) 1 32,660 32,660 15,356 Convertible Note Payable - LGC (8%) 2 125,000 - 125,000 22,713 Convertible Note Payable - LGC (8%) 3 125,000 - - 125,000 22,743 Convertible Note Payable - LGC (8%) 4 125,000 - - 125,000 22,768 Convertible Note Payable - MLM (10%) (Related party) 51,005 - 51,005 28,741 Convertible Note Payable - LGC (8%) 5 78,750 (28,646 ) (462 ) 49,642 8,354 Convertible Note Payable - LGC (8%) 6 52,500 (26,803 ) (808 ) 24,889 16,972 Convertible Notes Payable- PULG (8%) 1 65,000 (63,610 ) (2,244 ) (854 ) 35,933 Convertible Notes Payable- PULG (8%) 2 58,000 (47,690 ) (2,655 ) 7,655 36,818 $ 791,855 $ - $ (212,235 ) $ (6,169 ) $ 573,451 $ 263,468
Notes converted $110 [Member]
Short-term Debt [Line Items]
Schedule of convertible note conversion	Date of Conversion Principal Amount Converted Conversion Rate Shares Received June 2013 $ 70 $ 0.0001 700 August 2013 $ 40 $ 0.0001 400
New note holder converted an additional $90 [Member]
Short-term Debt [Line Items]
Schedule of convertible note conversion	Date of Conversion Principal Amount Converted Conversion Rate Shares Received November 2013 $ 40 $ 0.0001 400 December 2013 $ 50 $ 0.0001 500
New note holder converted an additional $90 one [Member]
Short-term Debt [Line Items]
Schedule of convertible note conversion	Date of Conversion Principal Amount Converted Conversion Rate Shares Received March 2014 $ 50 $ 0.0001 500 April 2014 $ 40 $ 0.0001 400
Note converted $1,010 [Member]
Short-term Debt [Line Items]
Schedule of convertible note conversion	Date of Conversion Principal Amount Converted Conversion Rate Shares Received December 2012 $ 150 $ 0.001 150 January 2013 $ 660 $ 0.001 660 March 2013 $ 200 $ 0.001 200

Derivatives and Fair Value In_2

Derivatives and Fair Value Instruments (Tables)	12 Months Ended
	Dec. 31, 2018
Derivatives and Fair Value Instruments [Abstract]
Summary of derivative liabilities on convertible notes payable	12/31/2018 Original Derivative Quarter Ended Quarter Ended Ended March 31, Derivative Quarter Ended Quarter Ended Ended June 30, Derivative Quarter Ended Quarter Ended Ended September 30, Derivative Quarter Ended Quarter Ended Ended December 31, Derivative Convertible Derivative Treatment Maturity Principal Note Original Derivative Valuation December 31, March 31, 2018 March 31, 2018 2018 Mark-to- Valuation March 31, June 30, 2018 June 30, 2018 2018 Mark-to- Valuation June 30, September 30, 2018 September 30, 2018 2018 Mark-to- Valuation September 30, December 31, 2018 December 31, 2018 2018 Mark-to- Valuation December 31, Note Date Date Amount Valuation 2017 Issuances Conversions Market 2018 Issuances Conversions Market 2018 Issuances Conversions Market 2018 Issuances Conversions Market 2018 8% Convertible Note Payable-issued 5/2/2016 10/1/2016 5/2/2017 $ 57,750 $ 58,355 $ 24,925 $ (26,745 ) $ 5,123 $ 3,303 $ (665 ) $ 2,638 $ (2,740 ) $ 102 $ - $ - 5 % Convertible Note- Payable -issued 6/12/2015 4/12/2016 1/7/2017 35,863 37,827 $ 832 $ - 305 $ 1,137 (233 ) $ 904 211 $ 1,115 316 $ 1,431 8% Convertible Notes Payable-issued May 1, 2016 10/28/2017 5/1/2018 131,250 103,294 $ 52,989 $ (31,013 ) 8,541 $ 30,517 $ (9,148 ) 17,439 $ 38,808 $ (1,605 ) (11,075 ) $ 26,128 $ (10,591 ) (181 ) $ 15,356 8% Convertible Notes Payable-issued June 7, 2016 12/4/2017 6/7/2018 125,000 90,596 $ 64,458 (14,452 ) $ 50,006 55,818 $ 105,824 (75,201 ) $ 30,623 (7,815 ) $ 22,808 10% Convertible Notes Payable-issued March 8, 2016 9/15/2017 9/8/2018 150,000 167,164 $ 108,682 $ (19,359 ) 23,426 $ 112,749 $ (26,895 ) 44,802 $ 130,656 $ (17,872 ) (70,817 ) $ 41,967 $ (34,169 ) 20,943 $ 28,741 8% Convertible Notes Payable-issued August 15, 2017 4/1/2018 8/15/2018 125,000 108,878 $ - $ - 108,878 (3,760 ) $ 105,118 (74,541 ) $ 30,577 (7,834 ) $ 22,743 8% Convertible Notes Payable-issued July 10, 2017 4/1/2018 7/10/2018 125,000 108,061 $ - $ - 108,061 3,092 $ 111,153 (80,625 ) $ 30,528 (7,855 ) $ 22,673 8% Convertible Notes Payable-issued January 25, 2018 4/1/2018 1/25/2019 78,750 65,896 $ - $ - 65,896 135 $ 66,031 (44,217 ) $ 21,814 (13,460 ) $ 8,354 8% Convertible Notes Payable-issued June 4, 2017 6/4/2018 6/4/2018 52,500 42,755 $ - $ - 42,755 532 $ 43,287 (14,084 ) $ 29,203 (12,231 ) $ 16,972 8% Convertible Notes Payable-issued August 2, 2017 10/1/2018 8/2/2020 50,000 $ 99,234 $ (6,927 ) (40,668 ) $ 51,639 8% Convertible Notes Payable-issued October 1, 2018 10/1/2018 4/1/2020 58,000 $ 49,952 (13,134 ) $ 36,818 8% Convertible Notes Payable-issued November 19, 2018 11/19/2018 5/19/2020 65,000 $ 66,134 (30,201 ) $ 35,933 $ 1,054,113 $ 782,826 $ 251,886 $ - $ (77,117 ) $ 22,943 $ 197,712 $ 325,590 $ (36,043 ) $ 117,160 $ 604,419 $ - $ (22,217 ) $ (370,247 ) $ 211,955 $ 215,320 $ (51,687 ) $ (112,120 ) $ 263,468
Summary of market fair value adjustment	Mark-to market fair value adjustment for the quarter ended March 31, 2018 $ 22,943 Mark-to market fair value adjustment for the quarter ended June 30, 2018 117,160 Mark-to market fair value adjustment for the quarter ended September 30, 2018 (370,247 ) Mark-to market fair value adjustment for the quarter ended December 31, 2018 (112,120 ) Total mark-to market fair value adjustment for the year ended December 31, 2018 $ (342,264 )

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2018
Stockholders' Equity [Abstract]
Schedule of fair value issuance is estimated using Black-Scholes option-pricing model assumptions	Expected volatility 403% to 435% Expected life 0.7 Risk free interest rate 2.75% Dividend yield 0.00%

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2018
Commitments and Contingencies [Abstract]
Schedule of minimum required lease payments	2019 24,600 2020 24,600 2021 4,100

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2018
Income Taxes [Abstract]
Summary of NOLs, estimated deferred tax asset and valuation allowance of tax	Year Ended December 31, Net Estimated 2010 $ 4,457 $ 1,337 2011 34,325 $ 10,298 2012 174,024 $ 52,207 2013 114,267 $ 34,280 2014 294,880 $ 88,464 2015 121,619 $ 36,486 2016 382,095 $ 114,629 2017 1,148,020 $ 344,406 2018 629,038 $ 188,711 Total $ 2,902,725 $ 870,818 Less: Valuation Allowance $ (870,818 ) Net Deferred Tax Asset $ -
Schedule of statutory federal and state income tax rates to the loss before income taxes	December 31, December 31, 2018 2017 Statutory federal income tax rate 21 % 21 % State income taxes, net of federal taxes 9 % 9 % Valuation allowance (30 )% (30 )% Effective income tax rate 0 % 0 %

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Dec. 31, 2018
Related Party Transactions [Abstract]
Summary of owed amounts to related parties	December 31, December 31 2018 2017 Due to Related Party $ 8,921 $ 8,921 Due to officer/stockholder 8,955 8,398 Due to other stockholders 3,100 6,790 Total Related Party Obligations $ 20,976 $ 24,109

Nature of Operations and Summ_3

Nature of Operations and Summary of Significant Accounting Policies (Details) - USD ($)

1 Months Ended

3 Months Ended

12 Months Ended

Jul. 23, 2018

Jul. 01, 2018

Sep. 25, 2017

Aug. 19, 2015

Jun. 30, 2018

Mar. 31, 2018

Dec. 31, 2017

Dec. 31, 2018

Dec. 31, 2015

Dec. 31, 2014

Apr. 18, 2018

Dec. 31, 2016

Nature of Operations and Summary of Significant Accounting Policies (Textual)

Cash equivalents

$ 287,569

$ 83,387

$ 165,017

Estimated useful lives of assets

5 years

Cost of licensing agreement is being amortized term period

10 years

Equity method investment, ownership percentage

100.00%

100.00%

80.00%

Minority Interest

20.00%

Fair value of acquired entity

$ 20

$ 20

Cash payment for purchase of CCRx common stock upon acquisition

$ 20

Total purchase price, per share

$ 0.001

Total purchase price of shares

20,000

Conversion of stock, shares

39,714

727,323

Principal balance

$ 133,750

$ 51,005

Reverse stock split, description

The Company effected a 1-for-1,000 reverse stock split of its issued and outstanding common stock. The number of shares of common stock issued and outstanding post- reverse stock split is 1,404,073.

Principal payment to unrelated third-party

$ 20,000

$ 16,650

Preferred Class B

Nature of Operations and Summary of Significant Accounting Policies (Textual)

Issuance of series B preferred shares as part consideration for license agreement, shares

25,000

Conversion of stock, shares

25,000

Convertible notes payable to investor

$ 150,000

Cash principal paydowns

32,550

Additional conversions to common stock

$ 33,345

Promissory Note [Member]

Nature of Operations and Summary of Significant Accounting Policies (Textual)

Conversion of stock, shares

25,000

60,000

Convertible notes payable to investor

$ 16,250

$ 15,000

Convertible notes payable converted into common stock

2,400

2,500

Property, Plant and Equipment_3

Property, Plant and Equipment (Net) (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Property, Plant and Equipment (Net) [Abstract]
Computer equipment	$ 8,956	$ 8,956
Less: accumulated depreciation	(8,365)	(7,725)
Total	$ 592	$ 1,232

Property, Plant and Equipment_4

Property, Plant and Equipment (Net) (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Property, Plant and Equipment (Net) (Textual)
Depreciation expense	$ 640	$ 640

Due to Related Party (Details)

Due to Related Party (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Due to Related Party (Textual)
Due to related party	$ 8,921	$ 8,921

Loans Payable - Stockholders (D

Loans Payable - Stockholders (Details) - USD ($)	1 Months Ended		12 Months Ended
	Feb. 28, 2017	Dec. 31, 2012	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2015	Dec. 31, 2014	Apr. 30, 2014
Loans Payable - Stockholders (Textual)
Stockholder of company advance			$ 557	$ 0
Loan			8,955	8,398
Stockholder [Member]
Loans Payable - Stockholders (Textual)
Shareholder indebted amount			$ 1,000	$ 1,500
Interest rate			26.70%
Promissory note due date	Jan. 1, 2014
Investor and noteholder [Member]
Loans Payable - Stockholders (Textual)
Principal amount converted	$ 500
Debt conversion convertible shares, subsequent to the year end	5,000
Promissory Note [Member]
Loans Payable - Stockholders (Textual)
Shareholder indebted amount		$ 5,000
Interest rate		10.00%
Promissory note due date		Jun. 2, 2013
Conversion price per share							$ 0.0001
Principal amount converted					$ 2,400	$ 2,500
Debt conversion convertible shares, subsequent to the year end					2,400	2,500

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - Notes converted $110 [Member]	12 Months Ended
	Dec. 31, 2018USD ($)$ / sharesshares
June 2013 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 70
Conversion Rate | $ / shares	$ 0.0001
Shares Received | shares	700
August 2013 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 40
Conversion Rate | $ / shares	$ 0.0001
Shares Received | shares	400

Convertible Notes Payable (De_2

Convertible Notes Payable (Details 1) - An additional $90 of note [Member]	12 Months Ended
	Dec. 31, 2018USD ($)$ / sharesshares
November 2013 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 40
Conversion Rate | $ / shares	$ 0.0001
Shares Received | shares	400
December 2013 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 50
Conversion Rate | $ / shares	$ 0.0001
Shares Received | shares	500

Convertible Notes Payable (De_3

Convertible Notes Payable (Details 2) - An additional $90 of note [Member]	12 Months Ended
	Dec. 31, 2018USD ($)$ / sharesshares
March 2014 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 50
Conversion Rate | $ / shares	$ 0.0001
Shares Received | shares	500
April 2014 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 40
Conversion Rate | $ / shares	$ 0.0001
Shares Received | shares	400

Convertible Notes Payable (De_4

Convertible Notes Payable (Details 3) - Note converted $1,010 [Member]	12 Months Ended
	Dec. 31, 2018USD ($)$ / sharesshares
December 2012 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 150
Conversion Rate | $ / shares	$ 0.001
Shares Received | shares	150
January 2013 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 660
Conversion Rate | $ / shares	$ 0.001
Shares Received | shares	660
March 2013 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 200
Conversion Rate | $ / shares	$ 0.001
Shares Received | shares	200

Convertible Notes Payable (De_5

Convertible Notes Payable (Details 4) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Short-term Debt [Line Items]
Remaining Principal Amount	$ 791,855
Original Issue Discount
Derivative Discount	(212,235)
Deferred Financing Costs	(6,169)
Total Convertible Notes Payable	522,446	$ 280,351
Derivative Liability	263,468	$ 251,886
Note Payable - BS [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	125
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	125
Derivative Liability
Note Payable - SF [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	60
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	60
Note Payable - SD [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	15,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	15,000
Note Payable - NW [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	715
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	715
Note Payable - MC #2 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	890
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	890
Convertible Note Payable - JR (5%) [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	45,500
Original Issue Discount
Derivative Discount	(45,486)
Deferred Financing Costs
Total Convertible Notes Payable	14
Derivative Liability	51,639
Convertible Note Payable - HG (10%) [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	16,650
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	16,650
Convertible Note Payable - CB (5%) [Member]
Short-term Debt [Line Items]
Remaining Principal Amount
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable
Derivative Liability	1,431
Convertible Notes Payable- SO (8%) [Member]
Short-term Debt [Line Items]
Remaining Principal Amount
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Convertible Note Payable - LGC (8%) 1 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	32,660
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	32,660
Derivative Liability	15,356
Convertible Note Payable - LGC (8%) 2 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	125,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	125,000
Derivative Liability	22,713
Convertible Note Payable - LGC (8%) 3 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	125,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	125,000
Derivative Liability	22,743
Convertible Note Payable - LGC (8%) 4 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	125,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	32,550
Derivative Liability	22,768
Convertible Note Payable - MLM (10%) (Related party) [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	51,005
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	51,005
Derivative Liability	28,741
Convertible Note Payable - LGC (8%) 5 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	78,750
Original Issue Discount
Derivative Discount	(28,646)
Deferred Financing Costs	(462)
Total Convertible Notes Payable	49,642
Derivative Liability	8,354
Convertible Note Payable - LGC (8%) 6 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	52,500
Original Issue Discount
Derivative Discount	(26,803)
Deferred Financing Costs	(808)
Total Convertible Notes Payable	24,889
Derivative Liability	16,972
Convertible Notes Payable- PULG (8%) 1
Short-term Debt [Line Items]
Remaining Principal Amount	65,000
Original Issue Discount
Derivative Discount	(63,610)
Deferred Financing Costs	(2,244)
Total Convertible Notes Payable	(854)
Derivative Liability	35,933
Convertible Notes Payable- PULG (8%) 2
Short-term Debt [Line Items]
Remaining Principal Amount	58,000
Original Issue Discount
Derivative Discount	(47,690)
Deferred Financing Costs	(2,655)
Total Convertible Notes Payable	7,655
Derivative Liability	$ 36,818

Convertible Notes Payable (De_6

Convertible Notes Payable (Details Textual) - USD ($)	1 Months Ended															3 Months Ended	12 Months Ended
	Apr. 30, 2017	Jan. 31, 2017	Aug. 31, 2016	Apr. 30, 2015	Oct. 31, 2014	Apr. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Nov. 30, 2013	Oct. 31, 2013	Sep. 30, 2013	Aug. 31, 2013	Jul. 31, 2013	May 31, 2012	Mar. 31, 2011	Jun. 30, 2018	Dec. 31, 2018	Dec. 31, 2017
Convertible Notes Payable (Textual)
Principal amount transferred to shareholders/third party												$ 330
Retired amount of notes																	$ 32,550
Amount of accrued interest transferred												$ 55
Remaining principal of note																	890	$ 890
Issued aggregate principal amount																$ 20,000	16,650
6% convertible notes [Member]
Convertible Notes Payable (Textual)
Maturity of convertible notes															January 2012
Interest rate on notes															6.00%
Issued aggregate principal amount															$ 800
Notes converted $110 [Member]
Convertible Notes Payable (Textual)
Converted shares of common stock											1,000	50			1,100
Principal amount converted											$ 100	$ 5			$ 110
Notes converted $110 [Member] | Third Party [Member]
Convertible Notes Payable (Textual)
Converted shares of common stock											350
Principal amount converted											$ 35
New note holder converted an additional $90 [Member]
Convertible Notes Payable (Textual)
Converted shares of common stock						900,000	900,000	900,000	900,000
Principal amount converted						$ 90	$ 90	$ 90	$ 90
Remaining principal of note																	$ 125
Note Payable-NW [Member]
Convertible Notes Payable (Textual)
Description of conversion of convertible notes													In August 2013, in a private transaction, the new note holder of the aforementioned note transferred $4,475 of principal to a stockholder of the company.
Issued aggregate principal amount													$ 9,690
Note Payable-SF [Member]
Convertible Notes Payable (Textual)
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock																	9.99%	9.99%
Conversion price per share													$ 0.0006				$ 0.0001	$ 0.0001
Converted shares of common stock													400				347,936	84,859
Principal amount converted													$ 240
Remaining principal of note																	$ 60	$ 60
Note Payable-SF One [Member]
Convertible Notes Payable (Textual)
Converted shares of common stock													300
Principal amount converted													$ 300
Remaining principal of note													9,690
Note Payable-NW [Member]
Convertible Notes Payable (Textual)
Conversion price per share										$ 0.001
Converted shares of common stock										400
Principal amount converted										$ 400
Note Payable-NW One [Member]
Convertible Notes Payable (Textual)
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock																	9.99%	9.99%
Conversion price per share																	$ 0.001	$ 0.001
Converted shares of common stock					1,100
Principal amount converted					$ 1,100
Issuance of common shares																	347,936	84,858,757
Note Payable-RK [Member]
Convertible Notes Payable (Textual)
Maturity of convertible notes														November 2012
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock														9.99%
Retired amount of notes													$ 14,000
Interest rate on notes														6.00%
Conversion price per share														$ 0.001
Converted shares of common stock														1,010
Principal amount converted														$ 1,010
Description of conversion of convertible notes														The note plus any accrued but unpaid interest were convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock.
Issued aggregate principal amount														$ 25,000
Note Payable-MC #2 [Member]
Convertible Notes Payable (Textual)
Maturity of convertible notes				October 2015
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock				8.00%
Principal amount transferred to shareholders/third party		$ 600
Converted shares of common stock	6,000	11,000	3,000,000															6,000
Principal amount converted	$ 410	$ 1,100	$ 3,000															$ 600
Remaining principal of note																	$ 715	$ 715
Description of conversion of convertible notes				The holder of the note has the right to convert the principal into shares of the Company's common stock at any time 180 days after the closing date at $0.0001 per share. Interest on the note accrues interest at 8% per annum and is payable when the note matures.
Issued aggregate principal amount				$ 3,000
Issuance of common shares		6,000

Convertible Notes Payable (De_7

Convertible Notes Payable (Details Textual 1)

Jun. 04, 2018USD ($)

Aug. 02, 2017USD ($)$ / shares

Jun. 02, 2017USD ($)

Oct. 11, 2016USD ($)

May 02, 2016USD ($)

Mar. 15, 2016USD ($)

Mar. 08, 2016USD ($)shares

Jan. 13, 2016USD ($)LaserDevices

Jan. 07, 2016USD ($)

Nov. 19, 2018USD ($)

Oct. 31, 2018USD ($)

Oct. 03, 2018

May 26, 2018USD ($)

Jan. 25, 2018USD ($)

Sep. 25, 2017USD ($)shares

Jun. 30, 2017USD ($)

May 01, 2017USD ($)

Apr. 30, 2017shares

Jun. 30, 2016USD ($)

Jun. 15, 2016USD ($)

May 31, 2016USD ($)

Dec. 31, 2018USD ($)shares

Sep. 30, 2018USD ($)shares

Jun. 30, 2018USD ($)shares

Mar. 31, 2018USD ($)shares

Dec. 31, 2017USD ($)shares

Jun. 30, 2017USD ($)shares

Mar. 31, 2017USD ($)shares

Dec. 31, 2018USD ($)shares

Dec. 31, 2017USD ($)shares

Oct. 02, 2018USD ($)

Sep. 30, 2017USD ($)

Dec. 31, 2016USD ($)

Convertible Notes Payable (Textual)

Gain on debt settlement

$ 34,235

Original issue, discount

Convertible notes payable

522,446

$ 280,351

522,446

280,351

Remaining principal of note

890

$ 890

$ 890

890

Conversion of stock, shares | shares

39,714

727,323

Principal outstanding balance

$ 52,500

Convertible Notes Payable-LG (9%) [Member]

Convertible Notes Payable (Textual)

Original issue, discount

Convertible Notes Payable- BBCG (9%) [Member]

Convertible Notes Payable (Textual)

Interest rate on notes

9.00%

Promissory note due date

Mar. 27, 2018

Original issue debt discount

$ 7,895

Debt discounted rate, percentage

57.50%

Original issue, discount

Convertible notes payable

125,000

125,000

Convertible notes payable, principal amount

$ 157,895

Convertible Notes Payable-LGC (8%) BEN [Member]

Convertible Notes Payable (Textual)

Interest rate on notes

8.00%

Promissory note due date

Jan. 7, 2017

Jan. 7, 2016

Convertible notes payable converted into common stock | shares

50,000

Debt instrument convertible redeemable description

(i) a convertible redeemable note in principal amount of $105,000 containing an original issue discount of $20,000 (the "$105K Note"); and (ii) a convertible redeemable note in principal amount of $50,000 (the "$50K Note" and together with the $105K Note, the "Notes").

Proceeds from discount on legal fees

$ 75,697

Collateralized secured promissory note

$ 50,000

Beneficial ownership interest rate

9.99%

Common stock conversion of trading days | LaserDevices

20

Remaining principal of note

$ 46,803

$ 46,803

Principal amount converted

$ 105,000

16,000

Conversion price, description

Conversion price equal to 55% of the lowest trading price of Common Stock during the 20 trading day period prior to conversion.

Convertible notes payable, principal amount

$ 50,000

Convertible Notes Payable - LG Funding (8%) [Member]

Convertible Notes Payable (Textual)

Convertible notes payable converted into common stock | shares

69,439

Sale of convertible redeemable principal amount

$ 1,012,500

Remaining principal of note

32,660

32,660

Principal amount converted

$ 2,200

$ 21,500

15,350

Deducting of legal fees

25,000

Convertible notes payable, principal amount

$ 125,000

131,250

10,640

$ 131,250

10,640

$ 131,250

Accrued interest

$ 1,312

$ 1,312

Common stock issued on fully satisfied issuance | shares

38,870

Conversion of stock, shares | shares

148,545

193,384

35,058

350,358

Convertible notes issued date

Dec. 4, 2017

Purchase agreement, description

In consideration for the issuance of the $131K Note and the $125K Note, on May 1, 2017 and June 2, 2017 and for the two $125k Notes on July 10, 2017 and August 7, 2017, the Company received net proceeds (after deducting $25,000 in legal fees) in the amount of $481,250. In consideration for the issuance of the $131K and the three $125k Notes, the Investor issued to the Company a $131,250 fully-collateralized secured promissory note and three $125,000 fully-collateralized secured promissory notes (the "Investor Notes"),

Principal outstanding balance

$ 15,350

Convertible Note Payable - JR (5%) [Member]

Convertible Notes Payable (Textual)

Interest rate on notes

5.00%

Promissory note due date

Aug. 2, 2018

Original issue, discount

Conversion price per share | $ / shares

$ 0.003

Convertible notes payable

14

14

Remaining principal of note

45,500

45,500

Principal amount converted

$ 50,000

Convertible notes payable, principal amount

$ 4,500

50,000

4,500

$ 50,000

Common stock issued on fully satisfied issuance | shares

150,000

Convertible Notes Payable - MLM (10%) [Member]

Convertible Notes Payable (Textual)

Original issue, discount

Convertible notes payable

32,550

32,550

Convertible notes payable, principal amount

30,195

30,195

Convertible Notes Payable - LG (8%) [Member]

Convertible Notes Payable (Textual)

Interest rate on notes

8.00%

8.00%

Promissory note due date

Jun. 4, 2019

Jan. 25, 2019

Convertible notes payable, principal amount

$ 52,500

$ 78,750

Principal outstanding balance

78,750

Convertible Note Payable - LGC (8%) 3 [Member]

Convertible Notes Payable (Textual)

Principal outstanding balance

$ 46,803

$ 50,000

Convertible Notes Payable - PULG (8%) [Member]

Convertible Notes Payable (Textual)

Interest rate on notes

8.00%

8.00%

Promissory note due date

May 19, 2020

Apr. 30, 2020

Apr. 1, 2020

Principal amount converted

$ 65,000

$ 58,000

Convertible notes payable, principal amount

$ 58,000

Principal outstanding balance

$ 65,000

$ 58,000

January 1, 2018 [Member] | Convertible Notes Payable - LG Funding (8%) [Member]

Convertible Notes Payable (Textual)

Remaining principal of note

131,250

February 2, 2018 [Member] | Convertible Notes Payable - LG Funding (8%) [Member]

Convertible Notes Payable (Textual)

Remaining principal of note

125,000

March 10, 2018 [Member] | Convertible Notes Payable - LG Funding (8%) [Member]

Convertible Notes Payable (Textual)

Remaining principal of note

125,000

April 07, 2018 [Member] | Convertible Notes Payable - LG Funding (8%) [Member]

Convertible Notes Payable (Textual)

Remaining principal of note

$ 125,000

$131K Note [Member] | Convertible Notes Payable - LG Funding (8%) [Member]

Convertible Notes Payable (Textual)

Interest rate on notes

8.00%

Debt instrument convertible redeemable description

Pursuant to which the Investor agreed to pay the Company $131,250 and $375,000 on or before January 1, 2018, February 2, 2018, March 10, 2018 and April 7, 2018 respectively. These Notes (often referred to as "back-end Notes"), bear interest at the rate of 8% per annum.

Proceeds from discount on legal fees

$ 481,250

$ 481,250

Collateralized secured promissory note

131,250

Deducting of legal fees

25,000

Convertible notes payable, principal amount

131,250

$125K Note [Member] | Convertible Notes Payable - LG Funding (8%) [Member]

Convertible Notes Payable (Textual)

Convertible notes payable, principal amount

$ 125,000

94,400

$ 94,400

Common Stock [Member]

Convertible Notes Payable (Textual)

Convertible notes payable converted into common stock | shares

62,068

62,068

Remaining principal of note

Convertible notes payable, principal amount

$ 30,803

Conversion of stock, shares | shares

30,000

Principal outstanding balance

$ 7,500

Common Stock [Member] | Convertible Notes Payable - MLM (10%) [Member]

Convertible Notes Payable (Textual)

Principal amount converted

$ 3,350

Conversion of stock, shares | shares

120,000

Investor [Member]

Convertible Notes Payable (Textual)

Promissory note due date

May 2, 2017

Conversion date, description

The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion.

Sale of convertible redeemable principal amount

$ 251,803

Note receivables

$ 50,000

$ 46,803

Principal amount converted

$ 20,000

5% CONVERTIBLE NOTES PAYABLE

Convertible Notes Payable (Textual)

Convertible notes payable

Remaining principal of note

100,000

100,000

Convertible Note Payable-SO-B (8%) [Member]

Convertible Notes Payable (Textual)

Interest rate on notes

8.00%

Promissory note due date

May 2, 2017

Conversion date, description

The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion.

Debt discounted rate, percentage

10.00%

Convertible notes payable converted into common stock | shares

122,727

Convertible notes payable, principal amount

$ 57,750

Accrued interest

$ 12,896

$ 12,896

Conversion of stock, shares | shares

148,316

Leaving balance on original note

$ 2,452

Principal outstanding balance

$ 23,000

Convertible Note Payable-SO-B (8%) [Member] | Investor [Member]

Convertible Notes Payable (Textual)

Convertible notes payable converted into common stock | shares

23,490

Remaining principal of note

$ 25,452

$ 25,452

Principal amount converted

$ 32,298

Promissory Note [Member] | Convertible Notes Payable - LG Funding (8%) [Member]

Convertible Notes Payable (Textual)

Principal amount converted

$ 10,030

Conversion of stock, shares | shares

62,015

Promissory Note [Member] | Convertible Notes Payable - MLM (10%) [Member]

Convertible Notes Payable (Textual)

Convertible notes payable converted into common stock | shares

826,747

Convertible notes payable, principal amount

$ 16,250

Promissory note issued by company

$ 150,000

Accrued interest

$ 18,986

$ 18,986

Common stock issued on fully satisfied issuance | shares

17,273

495,000

Conversion of stock, shares | shares

25,000

Issuance of series B preferred shares as part consideration for license agreement, shares | shares

25,000

Principal outstanding balance

$ 51,005

Derivatives and Fair Value In_3

Derivatives and Fair Value Instruments (Details) - USD ($)	3 Months Ended				12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017
Derivative Liability [Abstract]
Derivative Valuation	$ 263,468				$ 251,886
Derivative Valuation [Member]
Derivative Liability [Abstract]
Principal Note Amount					1,054,113
Original Derivative Valuation					782,826
Issuances	215,320		$ 325,590
Conversions	(51,687)	(22,217)	(36,043)	(77,117)
Mark-to-Market	(112,120)	(370,247)	117,160	22,943
Derivative Valuation	263,468	211,955		197,712	$ 251,886
8% Convertible Note Payable-issued 5/2/2016 [Member]
Derivative Liability [Abstract]
Derivative Treatment Date					Oct. 1, 2016
Maturity Date					May 2, 2017
Principal Note Amount					$ 57,750
Original Derivative Valuation					58,355
Derivative Valuation					$ 24,925
8% Convertible Note Payable-issued 5/2/2016 [Member] | Quarter Ended March 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions				(26,745)
Mark-to-Market				5,123
Derivative Valuation				3,303
8% Convertible Note Payable-issued 5/2/2016 [Member] | Quarter Ended June 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market			(665)
Derivative Valuation			2,638
8% Convertible Note Payable-issued 5/2/2016 [Member] | Quarter Ended September 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions		(2,740)
Mark-to-Market		102
Derivative Valuation
8% Convertible Note Payable-issued 5/2/2016 [Member] | Quarter Ended December 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market
Derivative Valuation
5 % Convertible Note-Payable -issued 6/12/2015 [Member]
Derivative Liability [Abstract]
Derivative Treatment Date					Apr. 12, 2016
Maturity Date					Jan. 7, 2017
Principal Note Amount					$ 35,863
Original Derivative Valuation					37,827
Derivative Valuation					$ 832
5 % Convertible Note-Payable -issued 6/12/2015 [Member] | Quarter Ended March 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market				305
Derivative Valuation				1,137
5 % Convertible Note-Payable -issued 6/12/2015 [Member] | Quarter Ended June 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market			(233)
Derivative Valuation			904
5 % Convertible Note-Payable -issued 6/12/2015 [Member] | Quarter Ended September 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market		211
Derivative Valuation		1,115
5 % Convertible Note-Payable -issued 6/12/2015 [Member] | Quarter Ended December 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances	316
Conversions	1,431
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable-issued May 1, 2016 [Member]
Derivative Liability [Abstract]
Derivative Treatment Date					Oct. 28, 2017
Maturity Date					May 1, 2018
Principal Note Amount					$ 131,250
Original Derivative Valuation					103,294
Derivative Valuation					$ 52,989
8% Convertible Notes Payable-issued May 1, 2016 [Member] | Quarter Ended March 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions				(31,013)
Mark-to-Market				8,541
Derivative Valuation				30,517
8% Convertible Notes Payable-issued May 1, 2016 [Member] | Quarter Ended June 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions			(9,148)
Mark-to-Market			17,439
Derivative Valuation			38,808
8% Convertible Notes Payable-issued May 1, 2016 [Member] | Quarter Ended September 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions		(1,605)
Mark-to-Market		(11,075)
Derivative Valuation		26,128
8% Convertible Notes Payable-issued May 1, 2016 [Member] | Quarter Ended December 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances	(10,591)
Conversions	(181)
Mark-to-Market	15,356
Derivative Valuation
8% Convertible Notes Payable-issued June 7, 2016 [Member]
Derivative Liability [Abstract]
Derivative Treatment Date					Dec. 4, 2017
Maturity Date					Jun. 7, 2018
Principal Note Amount					$ 125,000
Original Derivative Valuation					90,596
Derivative Valuation					$ 64,458
8% Convertible Notes Payable-issued June 7, 2016 [Member] | Quarter Ended March 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market				(14,452)
Derivative Valuation				50,006
8% Convertible Notes Payable-issued June 7, 2016 [Member] | Quarter Ended June 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market			55,818
Derivative Valuation			105,824
8% Convertible Notes Payable-issued June 7, 2016 [Member] | Quarter Ended September 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market		(75,201)
Derivative Valuation		30,623
8% Convertible Notes Payable-issued June 7, 2016 [Member] | Quarter Ended December 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances	(7,815)
Conversions	22,808
Mark-to-Market
Derivative Valuation
10% Convertible Notes Payable-issued March 8, 2016 [Member]
Derivative Liability [Abstract]
Derivative Treatment Date					Sep. 15, 2017
Maturity Date					Sep. 8, 2018
Principal Note Amount					$ 150,000
Original Derivative Valuation					167,164
Derivative Valuation					$ 108,682
10% Convertible Notes Payable-issued March 8, 2016 [Member] | Quarter Ended March 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions				(19,359)
Mark-to-Market				23,426
Derivative Valuation				112,749
10% Convertible Notes Payable-issued March 8, 2016 [Member] | Quarter Ended June 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions			(26,895)
Mark-to-Market			44,802
Derivative Valuation			130,656
10% Convertible Notes Payable-issued March 8, 2016 [Member] | Quarter Ended September 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions		(17,872)
Mark-to-Market		(70,817)
Derivative Valuation		41,967
10% Convertible Notes Payable-issued March 8, 2016 [Member] | Quarter Ended December 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances	(34,169)
Conversions	20,943
Mark-to-Market	28,741
Derivative Valuation
8% Convertible Notes Payable-issued August 15, 2017 [Member]
Derivative Liability [Abstract]
Derivative Treatment Date					Apr. 1, 2018
Maturity Date					Aug. 15, 2018
Principal Note Amount					$ 125,000
Original Derivative Valuation					108,878
Derivative Valuation
8% Convertible Notes Payable-issued August 15, 2017 [Member] | Quarter Ended March 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable-issued August 15, 2017 [Member] | Quarter Ended June 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances			108,878
Conversions
Mark-to-Market			(3,760)
Derivative Valuation			105,118
8% Convertible Notes Payable-issued August 15, 2017 [Member] | Quarter Ended September 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market		(74,541)
Derivative Valuation		30,577
8% Convertible Notes Payable-issued August 15, 2017 [Member] | Quarter Ended December 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances	(7,834)
Conversions	22,743
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable-issued July 10, 2017 [Member]
Derivative Liability [Abstract]
Derivative Treatment Date					Apr. 1, 2018
Maturity Date					Jul. 10, 2018
Principal Note Amount					$ 125,000
Original Derivative Valuation					108,061
Derivative Valuation
8% Convertible Notes Payable-issued July 10, 2017 [Member] | Quarter Ended March 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable-issued July 10, 2017 [Member] | Quarter Ended June 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances			108,061
Conversions
Mark-to-Market			3,092
Derivative Valuation			111,153
8% Convertible Notes Payable-issued July 10, 2017 [Member] | Quarter Ended September 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market		(80,625)
Derivative Valuation		30,528
8% Convertible Notes Payable-issued July 10, 2017 [Member] | Quarter Ended December 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances	(7,855)
Conversions	22,673
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable-issued January 25, 2018 [Member]
Derivative Liability [Abstract]
Derivative Treatment Date					Apr. 1, 2018
Maturity Date					Jan. 25, 2019
Principal Note Amount					$ 78,750
Original Derivative Valuation					65,896
Derivative Valuation
8% Convertible Notes Payable-issued January 25, 2018 [Member] | Quarter Ended March 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable-issued January 25, 2018 [Member] | Quarter Ended June 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances			65,896
Conversions
Mark-to-Market			135
Derivative Valuation			66,031
8% Convertible Notes Payable-issued January 25, 2018 [Member] | Quarter Ended September 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market		(44,217)
Derivative Valuation		21,814
8% Convertible Notes Payable-issued January 25, 2018 [Member] | Quarter Ended December 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances	(13,460)
Conversions	8,354
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable-issued June 4, 2017 [Member]
Derivative Liability [Abstract]
Derivative Treatment Date					Jun. 4, 2018
Maturity Date					Jun. 4, 2018
Principal Note Amount					$ 52,500
Original Derivative Valuation					42,755
Derivative Valuation
8% Convertible Notes Payable-issued June 4, 2017 [Member] | Quarter Ended March 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable-issued June 4, 2017 [Member] | Quarter Ended June 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances			42,755
Conversions
Mark-to-Market			532
Derivative Valuation			43,287
8% Convertible Notes Payable-issued June 4, 2017 [Member] | Quarter Ended September 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market		(14,084)
Derivative Valuation		29,203
8% Convertible Notes Payable-issued June 4, 2017 [Member] | Quarter Ended December 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances	(12,231)
Conversions	(16,972)
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable-issued August 2, 2017 [Member]
Derivative Liability [Abstract]
Derivative Treatment Date					Oct. 1, 2018
Maturity Date					Aug. 2, 2020
Principal Note Amount					$ 50,000
8% Convertible Notes Payable-issued August 2, 2017 [Member] | Quarter Ended March 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable-issued August 2, 2017 [Member] | Quarter Ended June 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable-issued August 2, 2017 [Member] | Quarter Ended September 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market
Derivative Valuation		99,234
8% Convertible Notes Payable-issued August 2, 2017 [Member] | Quarter Ended December 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances	(6,927)
Conversions	(40,668)
Mark-to-Market	51,639
Derivative Valuation
8% Convertible Notes Payable-issued October 1, 2018 [Member]
Derivative Liability [Abstract]
Derivative Treatment Date					Oct. 1, 2018
Maturity Date					Apr. 1, 2020
Principal Note Amount					$ 58,000
8% Convertible Notes Payable-issued October 1, 2018 [Member] | Quarter Ended March 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable-issued October 1, 2018 [Member] | Quarter Ended June 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable-issued October 1, 2018 [Member] | Quarter Ended September 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market
Derivative Valuation		49,952
8% Convertible Notes Payable-issued October 1, 2018 [Member] | Quarter Ended December 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances	(13,134)
Conversions	36,818
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable-issued November 19, 2018 [Member]
Derivative Liability [Abstract]
Derivative Treatment Date					Nov. 19, 2018
Maturity Date					May 19, 2020
Principal Note Amount					$ 65,000
8% Convertible Notes Payable-issued November 19, 2018 [Member] | Quarter Ended March 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable-issued November 19, 2018 [Member] | Quarter Ended June 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable-issued November 19, 2018 [Member] | Quarter Ended September 30, 2018 [Member]
Derivative Liability [Abstract]
Issuances
Conversions
Mark-to-Market
Derivative Valuation		$ 66,134
8% Convertible Notes Payable-issued November 19, 2018 [Member] | Quarter Ended December 31, 2018 [Member]
Derivative Liability [Abstract]
Issuances	(30,201)
Conversions	(35,933)
Mark-to-Market
Derivative Valuation
8% Convertible Notes Payable- issued January 25, 2018 [Member] | Quarter Ended September 30, 2018 [Member]
Derivative Liability [Abstract]
Derivative Valuation
8% Convertible Notes Payable- issued June 4, 2017 [Member] | Quarter Ended September 30, 2018 [Member]
Derivative Liability [Abstract]
Derivative Valuation

Derivatives and Fair Value In_4

Derivatives and Fair Value Instruments (Details 1)	12 Months Ended
	Dec. 31, 2018USD ($)
Derivative [Line Items]
Total mark-to market fair value adjustment	$ (342,264)
Mark-to market fair value adjustment for the quarter ended March 31, 2018 [Member]
Derivative [Line Items]
Mark-to market fair value adjustment	22,943
Mark-to market fair value adjustment for the quarter ended June 30, 2018 [Member]
Derivative [Line Items]
Mark-to market fair value adjustment	117,160
Mark-to market fair value adjustment for the quarter ended September 30, 2018 [Member]
Derivative [Line Items]
Mark-to market fair value adjustment	(370,247)
Mark-to market fair value adjustment for the quarter ended December 31, 2018 [Member]
Derivative [Line Items]
Mark-to market fair value adjustment	$ (112,120)

Derivatives and Fair Value In_5

Derivatives and Fair Value Instruments (Details Textual)	12 Months Ended
	Dec. 31, 2018USD ($)
Derivatives and Fair Value Instruments (Textual)
Derivative, description	The 5% Convertible Note Payable and the 8% Convertible Notes Payable and the 9% convertible note payable are valued at December 31,2018. The following assumptions were used for the valuation of the embedded derivative:- The stock price (prior period reverse split 1,000:1) of $0.12 decreased to $0.0438 in this period (basis for the variable conversion prices) would fluctuate with the Company projected volatility- An event of default for the Convertible Note would occur 0% of the time, increasing 1.00% per month to a maximum of 5.0%;- Alternative financing for the Convertible Note would be initially available to redeem the note 0% of the time and increase monthly by 1% to a maximum of 10%;- Capital raising events (a single financing at 1 month from the valuation date) was previously a factor for the VV Note but are no longer projected. The full reset events projected to occur based on future stock issuance (single event) result in a reset exercise price.-The monthly trading volume would average $458,000 (rounded) as of 12/31/18 and would increase at 5% per month; ownership limits conversion across LG's notes based on 4.99% with shares outstanding increasing monthly by 1%.- The variable conversion price of 45% to 58% over 3 to 20 trading days would have effective rates of 34.36% to 53.40%;- The Note Holders would automatically convert the notes early (and not hold to maturity) with variable conversion prices and full ratchet resets if the registration was effective and not in default;
Description of embedded derivative	The Company's 5% convertible notes payable and 8% convertible notes payable and 9% convertible note payable issued to unrelated investors is a hybrid instrument, which warrants separate accounting as a derivative instrument.
Fair value adjustment ((income)/expense)	$ (342,264)
Fair value instrument, description	The 5% Convertible Notes Payable issued June 12th 2015 and the 8% Convertible Note payable issued June 25th 2015 and for the 8% Convertible Notes Payable issued January 7, 2016 and March 7, 2016, the 9% Convertible Note payable issued October 1, 2016 the 8% Convertible Notes Payable issued January 25, 2018 and June 4, 2018 and the 8% converitble notes payable issued October 1, 2018 and November 19, 2018.
Fair Value, Inputs, Level 3 [Member]
Derivatives and Fair Value Instruments (Textual)
Fair value instrument, description	The Company's Level 3 financial liabilities consist of the 5% Convertible Notes Payable issued June 12th 2015 and the 8% Convertible Note payable issued June 25th 2015 and for the 8% Convertible Notes Payable issued January 7, 2016 and March 7, 2016 and May 1, 2017 and June 2, 2017 and July 10, 2017 and August 15, 2017, the 9% Convertible Note payable issued October 1, 2016, The 8% Convertible note payable issued January 25, 2018, the 8% Convertible note payable issued June 4, 2018 and the 8% converitble notes payable issued October 1, 2018 and November 19, 2018 for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation.
Maximum [Member]
Derivatives and Fair Value Instruments (Textual)
Projected annual volatility	240.00%
Minimum [Member]
Derivatives and Fair Value Instruments (Textual)
Projected annual volatility	145.00%

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - USD ($)	Oct. 12, 2018	Jul. 23, 2018	Dec. 31, 2018	Dec. 31, 2017	Sep. 19, 2017
Stockholders' Equity (Textual)
Reverse stock split, description		The Company effected a 1-for-1,000 reverse stock split of its issued and outstanding common stock. The number of shares of common stock issued and outstanding post- reverse stock split is 1,404,073.
Additional paid-in-capital increased			$ 140,169	$ 84,861
Common stock, shares authorized			4,000,000,000	4,000,000,000
Common stock, par value			$ 0.0001	$ 0.0001
Common stock, shares outstanding			3,482,840	849,437
Common stock, shares issued			3,482,840	849,437
Convertible preferred, stock description	The Company filed with the State of Nevada a certificate of designation pursuant to which the Company designated a new class of preferred stock as the Company's Series C Convertible Preferred Stock ("Series C Preferred") having a $100.00 stated value per share ("Stated Value") and a par value equal to $0.0001 per share. The Company designated 5,000 shares of Series C Preferred. Subject to a beneficial ownership limitation equal to 4.99%, each share of Series C Preferred is convertible into 25,000 shares of the Company's common stock .		At December 31, 2016 there were 39,000 shares issued of which 12,900 shares of Series B preferred were converted into common stock in accordance with the terms of the Series B Preferred stock. Therefore; there were 26,100 shares outstanding at December 31, 2016. The Series B preferred stock has no voting rights. During the quarter ended March 31, 2017, 18,100 shares of Series B preferred shares were converted into common stock in accordance with the terms of the Series B preferred stock. As of result there were 8,000 shares of Series B preferred shares outstanding at December 31, 2018. The holders of the Series B convertible preferred stock have the right to convert the same into Common Stock of the Corporation at the ratio of one (1) share of Series B Convertible Preferred for five hundred (500) shares of Common Stock.
Common Stock [Member]
Stockholders' Equity (Textual)
Common stock, shares authorized					4,000,000,000
Series A Preferred Stock [Member]
Stockholders' Equity (Textual)
Preferred stock, shares authorized			1,000,000	1,000,000
Preferred stock, par value			$ 0.0001	$ 0.0001
Preferred stock, shares issued			500,000	500,000
Preferred stock, shares outstanding			500,000	500,000
Preferred stock has preferential voting rights			The preferred stock has preferential voting rights of 2,000 votes per outstanding share.
Series B Preferred Stock [Member]
Stockholders' Equity (Textual)
Preferred stock, shares authorized			50,000	50,000
Preferred stock, par value			$ 0.0001	$ 0.0001
Preferred stock, shares issued			8,000	8,000
Preferred stock, shares outstanding			8,000	8,000
Series C Preferred Stock [Member]
Stockholders' Equity (Textual)
Preferred stock, shares authorized			5,000	5,000
Preferred stock, par value			$ 0.0001	$ 0.0001
Preferred stock, shares issued			177	0
Preferred stock, shares outstanding			177	0
Common stock stated value			$ 17,700
Professionals for their services total			$ 204,212

Stockholders' Equity (Details_2

Stockholders' Equity (Details Textual 1) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0001	$ 0.0001
March 31, 2018 [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	18,000
March 31, 2018 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0006
March 31, 2018 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0011
March 31, 2018 One [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	376,111
March 31, 2018 One [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0004
March 31, 2018 One [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0006
March 31, 2017 [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	43,000
March 31, 2017 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0028
March 31, 2017 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0094
March 31, 2017 One [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of notes, shares	112,498
March 31, 2017 One [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0001
March 31, 2017 One [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0028
March 31, 2017 Two [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	9,050
Stock issued during period shares issued for conversion of notes, shares	18,100
June 30, 2017 [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	33,000
June 30, 2017 [Member] | Series A Preferred Stock [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0001
Common stock issued for services, shares	450,000
June 30, 2017 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0022
June 30, 2017 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0028
June 30, 2017 One [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	177,072
June 30, 2017 One [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0001
June 30, 2017 One [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0028
September 30, 2017 [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	41,000
September 30, 2017 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0002
September 30, 2017 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0021
September 30, 2017 One [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	62,196
September 30, 2017 One [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.00065
September 30, 2017 One [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.00099
December 31, 2017 [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	71,000
December 31, 2017 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0006
December 31, 2017 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0011
December 31, 2017 One [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	74,772
December 31, 2017 One [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0004
December 31, 2017 One [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0006
June 30, 2018 [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of notes, shares	67,500
June 30, 2018 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0004
June 30, 2018 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Price per share	0.0004
June 30, 2018 one [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of notes, per shares	92,015
June 30, 2018 one [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Price per share	0.000174
June 30, 2018 one [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.00025
September 30, 2018 [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	634,053
September 30, 2018 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0525
September 30, 2018 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.18
September 30, 2018 One [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of notes, shares	427,755
September 30, 2018 One [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.0190
September 30, 2018 One [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.1173
December, 2018 [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of notes, shares	1,017,959
December, 2018 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.019
December, 2018 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Price per share	$ 0.025

Commitments and Contingencies_2

Commitments and Contingencies (Details)	Dec. 31, 2018USD ($)
Commitments and Contingencies [Abstract]
2019	$ 24,600
2020	24,600
2021	$ 4,100

Commitments and Contingencies_3

Commitments and Contingencies (Details Textual) - USD ($)	Sep. 12, 2016	Jul. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Commitments and Contingencies (Textual)
Current office space rate per month			$ 6,300
Commitments, description		The Company leased additional space at this location thereby increasing the monthly rent to $1,550.	The Company also has ready-to-go office space available to be used for meetings etc. at a nominal cost of approximately $100 per month with no commitment.
Payments for rent			$ 23,442
Office premises cost	$ 650
Lease agreement renewal term	3 years
Office premises cost term	1 year
Total rent expense			30,930	$ 20,713
Stockholder [Member]
Commitments and Contingencies (Textual)
Current office space rate per month			525
Payments for rent			$ 1,188
Dr. Ronald L. Rubin [Member]
Commitments and Contingencies (Textual)
Distribution agreement description			20% for direct sales 5% for any sale that he oversees that involves another sales person 5% for any sales related to a distribution agreement. He is to be issued 1 Series C Preferred share or 25,000 common shares per month
Dr. Gupta Pharma LLC [Member]
Commitments and Contingencies (Textual)
Distribution agreement description			The Company, via its subsidiary USA Pharma, has exclusive New Jersey distribution rights for all CBD products and non-exclusive rights to all other territories. The agreement is for a term of 3 years, but parties have the right to terminate. Upon agreement signing, 120 shares of Series C Convertible Preferred stock was issued by the Company to Dr. Gupta. Dr. Gupta shall have 30% of the issued and outstanding common stock of the Company during the term of this agreement. Should the percentage of ownership drop below 30% then the Company must issue additional Series C Convertible Preferred Shares which are convertible into the required additional amount of common stock minus 3,000,000 shares of common stock.

Income Taxes (Details)

Income Taxes (Details)	Dec. 31, 2018USD ($)
Operating Loss Carryforwards [Line Items]
Net Operating Loss	$ 2,902,725
Estimated Deferred Tax Asset	870,818
Less: Valuation Allowance	(870,818)
Net Deferred Tax Asset
2010 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	4,457
Estimated Deferred Tax Asset	1,337
2011 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	34,325
Estimated Deferred Tax Asset	10,298
2012 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	174,024
Estimated Deferred Tax Asset	52,207
2013 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	114,267
Estimated Deferred Tax Asset	34,280
2014 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	294,880
Estimated Deferred Tax Asset	88,464
2015 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	121,619
Estimated Deferred Tax Asset	36,486
2016 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	382,095
Estimated Deferred Tax Asset	114,629
2017 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	1,148,020
Estimated Deferred Tax Asset	344,406
2018 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	629,038
Estimated Deferred Tax Asset	$ 188,711

Income Taxes (Details 1)

Income Taxes (Details 1)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Taxes [Abstract]
Statutory federal income tax rate	21.00%	21.00%
State income taxes, net of federal taxes	9.00%	9.00%
Valuation allowance	(30.00%)	(30.00%)
Effective income tax rate	0.00%	0.00%

Income Taxes (Details Textual)

Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Contingency [Line Items]
Net operating loss carryforward	$ 2,902,725
Operating loss carryforward expiration period, description	Reduce future federal taxable income which begins to expire in the year 2030
Federal or state tax examinations, description	The Company currently has no federal or state tax examinations in progress, nor has it had any federal or state examinations since its inception. All of the Company's open tax years beginning in tax year 2014 are subject to federal and state tax examinations.
Net operating loss carryover, expiration date	Dec. 31, 2030
Deferred tax assets net operating losses		$ 146,337	$ 484,037
Statutory federal income tax rate	21.00%	21.00%
Income taxes rates and years description	Under the current Tax Cuts and Jobs Act (H.R. 1) (the "Act"), federal net operating losses generated after December 31, 2017 can be carried forward indefinately but only 80% of taxable income can be osffest with a net-operating loss deduction. Net operating losses generated in years 2017 and prior may be fully utilized up to 100% of taxable income and they still maintain their 20-year carry-forward life.
Maximum [Member]
Income Tax Contingency [Line Items]
Corporate income tax rate		34.00%	34.00%
Minimum [Member]
Income Tax Contingency [Line Items]
Corporate income tax rate		21.00%	21.00%

Stockholders' Equity (Details)

Stockholders' Equity (Details) - Series C Preferred Stock [Member]	12 Months Ended
	Dec. 31, 2018
Class of Stock [Line Items]
Expected life	8 months 12 days
Risk free interest rate	2.75%
Dividend yield	0.00%
Maximum [Member]
Class of Stock [Line Items]
Expected volatility	435.00%
Minimum [Member]
Class of Stock [Line Items]
Expected volatility	403.00%

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Owed amounts of related parties
Due to Related Party	$ 8,921	$ 8,921
Due to officer/stockholder	8,955	8,398
Due to other stockholders	3,100	6,790
Total Related Party Obligations	$ 20,976	$ 24,109

Related Party Transactions (D_2

Related Party Transactions (Details Textual) - USD ($)	1 Months Ended			3 Months Ended						12 Months Ended
	Sep. 30, 2017	Sep. 25, 2017	Dec. 31, 2012	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Jun. 30, 2017	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2015	Dec. 31, 2014	Jul. 01, 2018	Dec. 31, 2016	Aug. 19, 2015
Related Party Transactions (Textual)
Accrued compensation												$ 30,000			$ 18,974
Fair value of acquired entity														$ 20		$ 20
Officer's base compensation										$ 150,000	$ 112,500
Accrued CEO compensation was converted to Series A Preferred shares							$ 45
Conversion of stock, shares						39,714				727,323
Accrued expenses - officer's compensation						$ 401,079				$ 388,981	401,079
Related-party noteholder, description				The original related-party noteholder sold $20,000 in principal on this note to an unrelated third party investor thereby leaving $80,250 in principal balance due to the related party original noteholder and $20,000 in principal due to the unrelated third-party investor.
Convertible notes payable						280,351				522,446	$ 280,351
Principal outstanding balance										$ 52,500
Series B Preferred Stock [Member]
Related Party Transactions (Textual)
Issuance of series B preferred shares as part consideration for license agreement, shares										25,000
Issuance of common shares upon conversion of shares								18,100	3,400
Converted into shares of common stock								9,050	1,700	30,000
Convertible notes payable to investor										$ 150,000
Conversion of stock, shares										25,000
Common Stock [Member]
Related Party Transactions (Textual)
Convertible notes payable to investor	$ 30,803
Conversion of stock, shares				30,000
Convertible notes payable converted into common stock										62,068	62,068
Principal outstanding balance				$ 7,500
Promissory Note [Member]
Related Party Transactions (Textual)
Accrued interest										$ 18,986
Common stock issued on fully satisfied issuance										17,273
Convertible notes payable to investor		$ 16,250			$ 15,000
Conversion of stock, shares		25,000			60,000
Interest rate			10.00%
Promissory note due date			Jun. 2, 2013
Convertible notes payable converted into common stock												2,400	2,500
Principal amount converted												$ 2,400	$ 2,500
Promissory Note [Member] | Common Stock [Member]
Related Party Transactions (Textual)
Conversion of stock, shares										120,000
Convertible notes payable converted into common stock										495,000
Sale of convertible redeemable principal amount										$ 16,650
Convertible notes payable										3,350
Principal amount converted										30,195
Principal outstanding balance										51,005
Cash paydowns										$ 32,550
Chief Executive Officer [Member]
Related Party Transactions (Textual)
Accrued compensation	25,500					$ 44,673					$ 44,673
Officer's base compensation												$ 100,000	$ 100,000
Increase annual salary	$ 150,000

Basis of Reporting - Going Co_2

Basis of Reporting - Going Concern (Details)	Dec. 31, 2018USD ($)
Basis of Reporting - Going Concern (Textual)
Net operating loss carryforward	$ 2,902,725

Stock Compensation - Equity I_2

Stock Compensation - Equity Incentive Plan (Details) - shares	Dec. 06, 2016	Jan. 31, 2018	May 31, 2017	Jul. 31, 2016	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
2016 Equity Incentive Plan [Member]
Stock Compensation - Equity Incentive Plan (Textual)
Aggregate of shares of common stock				20,000,000
Common stock to non-employees for services rendered								27,100
Issuance of common shares	32,000							0
2017 Equity Incentive Plan [Member]
Stock Compensation - Equity Incentive Plan (Textual)
Aggregate of shares of common stock			125,000
Common stock to non-employees for services rendered										108,000
Issuance of common shares										17,000
2018 Equity Incentive Plan [Member]
Stock Compensation - Equity Incentive Plan (Textual)
Aggregate of shares of common stock		175,000
Common stock to non-employees for services rendered						17,500	4,000
Issuance of common shares					170,500	170,500	188,000		170,500

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Feb. 04, 2019	Oct. 05, 2018	Feb. 27, 2019	Feb. 25, 2019	Feb. 20, 2019	Jan. 24, 2019	Dec. 31, 2018
2019 Equity Incentive Plan [Member]
Subsequent Events (Textual)
Common stock issued for services, shares							277,000
Common stock shares, description							The total number of shares of Common Stock which may be purchased or granted directly by Options, Stock Awards or Restricted Stock Purchase Offers, or purchased indirectly through exercise of Options granted under the Plan shall not exceed Five Million (5,000,000). Subsequent to the year end, the Company issued 277,000 shares under this plan.
Convertible Promissory Notes [Member]
Subsequent Events (Textual)
Debt conversion convertible shares, subsequent to the year end							2,049,043
Aggregate principal amount, subsequent to the year end							$ 34,038
Accrued interest							$ 2,977
Preferred stock, description							The Company issued an aggregate 52 shares of Series C Convertible Preferred Stock to consultants for services performed. These 52 shares of Series C Convertible Preferred Stock are convertible into 1,550,000 shares of common stock of the Company. These 52 shares of Series C Convertible Preferred Stock will be recorded on the Company's books at fair value using a Black-Scholes pricing model.
Consultants for services [Member]
Subsequent Events (Textual)
Common stock issued for services, shares							277,000
Securities Purchase Agreement [Member]
Subsequent Events (Textual)
Issue a convertible promissory note		$ 58,000
Note pays interest rate		8.00%
Date of maturity		Apr. 1, 2020
Subsequent Event [Member] | Securities Purchase Agreement [Member]
Subsequent Events (Textual)
Issue a convertible promissory note	$ 38,000			$ 65,000	$ 54,000	$ 43,000
Note pays interest rate	12.00%			12.00%	8.00%	12.00%
Date of maturity	Nov. 30, 2019			Feb. 25, 2020	Aug. 20, 2019	Nov. 15, 2019
Convertible promissory note, description			The Company entered into a Securities Purchase Agreement with an investor to issue a convertible promissory note in the amount of $154,500. The note pays 8% interest per annum and contains a $15,000 original issue discount (OID). The note is to be funded in two tranches. After funding of the initial tranche, the principal balance of the note will be $51,500 which includes the first tranche of $46,500 and $,5000 of pro-rated OID. The maturity date for each tranche shall be 18 months from the effective date of each tranche payment. At any time after the date of the note, the investor may convert the principal balance of the note into common stock of the Company. On March 1, 2019 the cash funding for the inital tranche was received by the Company and the convertible note issued to the investor.